DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	FOXE1; MEIS2; TBX3; SNAI2; SOX15; ZNF205; IL33; TFAP2A; GLI3; BMP4; HOXD8; EFNA1; FGFR2; CCND1; NR2F2; HOXC8; MSX2; FRK; SOX2; SOX9; HMGA2; PLK1; PRRX1; FOXA1; FOXL2; ISL1; NKX3-2; TBX2; TRIM29; SIM2; FHL2; HES1; SIX1; KCTD1; OSR1; PPP1R13L; TFAP2C; AJUBA; SMO; FOXC2; IRX2; WWTR1; TP63; TRPV4; TFCP2L1; LMCD1; TAGLN3; DLX2; NFIB; TBX18; HES2;	GO:0000122~negative regulation of transcription by RNA polymerase II	51	847	6.02125147579693	0	0	0	0	0	0	0
up	TMPRSS2; TLL1; TMPRSS11D; KLK8; CFI; MMP2; MMP10; C1S; ENDOU; PRSS3; KLK7; FOLH1; ESPL1; CLCA4; PRSS8; THSD4; SFRP1; ADAMTSL1; ADAMTS15; RHBDF1; LGMN; MMP19; PRSS27; PAPPA2; TINAGL1; TMPRSS4; RHBDL2; FBXL2; TMPRSS11E; CLCA2; KLK5; CPA6; CAPN6; PLAT; CAPN14;	GO:0006508~proteolysis	35	436	8.02752293577982	0	0	0	0	0	0	0
up	EFS; NRP2; DSCAM; PTPRF; ITGB6; VCAM1; KITLG; CDH3; LAMA1; EPHA2; EFNB2; EMP2; MFAP4; CDH11; BCAR1; CX3CL1; SRPX; TYRO3; DDR1; LGALS3BP; CNTN1; TPBG; LAMC2; DSG2; HES1; POSTN; PPFIBP1; EGFL6; MAGI1; BOC; NTM; CLCA2; ROBO1; PCDHB8; PCDHB13; PCDHAC2; PCDHA11; PCDH7; PCDHB14; PCDHB10; PCDHGC5; PCDHGC3; PCDHGA9; PARD3; PCDHGB5; PCDHA12;	GO:0007155~cell adhesion	46	454	10.1321585903084	0	0	0	0	0	0	0
up	PCDH7; DSCAM; CDH1; CDH13; DSG2; NECTIN2; CADM1; TENM3; PCDHB8; PCDHB10; PCDHGC3; PCDHA12; PCDHB14; PCDHB13; PCDHGC5; PCDHGB5; PCDHGA9; PCDHA11; PCDHAC2; ROBO1; VSTM2L; IGSF9; CDH11; CDH26; CDH3; CDH10;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	26	165	15.7575757575758	0	0	0	0	0	0	0
up	HMGB3; RECQL4; HOXC6; CSF3; HMGA2; HUNK; ELF3; FGD1; CSRP2; HLF; ANO1; KCTD11; TXNRD3; EGFL6; VANGL1; TWIST2; EDARADD; CADM1; SCUBE2; OLFML3; NKX1-2; GTF2IRD1; EPHA2; FGFR2; TYRO3; ROR1; CDH11; ERBB2; DDR1; CDH3; CDH13; FSTL1; NTRK2; CDH10; CDH26; CDH1; MET; KDR;	GO:0007275~multicellular organism development	38	513	7.40740740740741	0	0	0	0	0	0	0
up	MATN2; FLRT2; NRP2; DSCAM; SLIT3; NFASC; NGFR; GLI3; BMP7; GPC1; GDNF; WNT5A; ETV1; LAMB2; VLDLR; SEMA3F; CRMP1; FOXD1; ARTN; APBB2; NRTN; BOC; FLRT3; ROBO1; VSTM2L; IGSF9; LAMA1; EFNB2; UNC5B; EPHA2; EFNA1; EFNB3;	GO:0007411~axon guidance	32	206	15.5339805825243	0	0	0	0	0	0	0
up	DLL1; TBX3; LRP5; CLDN7; NTN1; FGF5; BMP4; FOSL1; EDN2; PTN; KITLG; FGFR2; ADRA1D; ALDH3A1; KDR; GDNF; LIFR; SOX9; EFNB2; CRIP2; EMP2; ISL1; CX3CL1; BNC1; CDC20; TBX2; LAMC2; HES1; NTRK2; IL34; SFRP1; HAS2; LGMN; S100A13; WWTR1; GAREM1; HOXC10; HILPDA; ERBB2; CSF3;	GO:0008284~positive regulation of cell population proliferation	40	490	8.16326530612245	0	0	0	0	0	0	0
up	FOXE1; PLXNB1; PTPRF; JUP; HOXA5; EFNA1; EPHA2; BDKRB1; EMP2; BCAR1; SHROOM2; DOCK1; HES1; SYDE1; MISP; ASAP3; RHBDF1; GPC6; LAMB3; TYRO3; KDR; SDC1; GPC1; LAMB2; ITGB6; PIK3C2G; EFS; RHOD;	GO:0016477~cell migration	28	225	12.4444444444444	0	0	0	0	0	0	0
up	DAPL1; DLL1; TLL1; SOX15; INHA; MGP; MAL; MDK; FOXL2; BNC1; NHLH2; MECOM; SIM2; SHB; CSRP2; ZNF423; ZNF750; NXN; CXCL17; TXNRD3; EGFL6; ARHGEF28; OSR1; TWIST2; EDARADD; MMP19; CADM1; NDRG4; DLX2; POU3F1; NKX2-8; KIAA1522; NR2F2; FOXA2; FOXA1; ETV1; ETV4; HES1; FOXC2; NKX3-2; EYA2; FOXD1; FSTL1; NHSL1; SOX2; FRK; SOX7; HES2; NKX1-2; SOX21; ELF3; CAV2; FOXE1;	GO:0030154~cell differentiation	53	572	9.26573426573426	0	0	0	0	0	0	0
up	MATN3; SPINT1; COL4A1; COL5A2; DCN; COL4A2; CDH1; ITGB6; VCAM1; FBLN1; LAMA1; LOX; FBN1; KDR; SERPINB5; SOX9; LAMB2; ELF3; DDR1; LAMB3; LAMC2; EGFLAM; VWA1; EGFL6; APBB2; MMP2; COL22A1; MMP10; MMP19; POSTN;	GO:0030198~extracellular matrix organization	30	230	13.0434782608696	0	0	0	0	0	0	0
up	KRT34; KRT75; KRT14; KRT6B; KRT8; IVL; KRT19; KRT16; KRT13; KRT5; JUP; KRT15; SPRR1B; SPRR2E; SPRR2D; SPRR1A; KRT6C; DSG2; KRT31; PRSS8; KRT24; KRT78; PKP2; KLK5; PKP3;	GO:0070268~cornification	25	113	22.1238938053097	0	0	0	0	0	0	0
down	TRAV2; IGLV3-21; IGKV3-11; IGLV5-45; IGLV3-19; IGLV2-14; TRDV2; IGLV4-69; IGLV2-23; IGKV3-20; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; TRAV14DV4; IGLV6-57; IGLV2-11; IGLV1-40; TRAV38-2DV8; IGLV3-1; IGLV1-44; IGKV1-5; IGLV3-25; IGLV8-61; IGLV7-43; IGLV3-9; TRAV38-1; TRAV9-2; TRAV19; IGLV1-47; IGKV3-15;	GO:0002377~immunoglobulin production	31	107	28.9719626168224	0	0	0	0	0	0	0
down	HP; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; HBA1; IGLV3-21; FCGR1B; STAB1;	GO:0006898~receptor-mediated endocytosis	41	160	25.625	0	0	0	0	0	0	0
down	IGHV3-11; IGHV4-39; IGHV3-74; IGLL5; IGHG2; IGHV3-30; IGHV1-2; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV3-21; IGLC3; IGHV3-23; IGHG3; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV4-59; IGHV4-34;	GO:0006910~phagocytosis, recognition	31	99	31.3131313131313	0	0	0	0	0	0	0
down	FCGR2B; AIF1; IGHG2; IGHV1-2; IGHV3-30; IGLC2; IGHV3-7; IGHA2; IGHV3-74; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV3-11; IGHV4-39; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-15; IGHV6-1; IGHG3; IGHV3-48; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHG4; IGHV1-18; IGHD; IGLL5; TRBC1; IGHV3-23; IGHV4-31;	GO:0006911~phagocytosis, engulfment	33	115	28.695652173913	0	0	0	0	0	0	0
down	NCR3; IL18RAP; LY86; ORM1; S100A8; FOLR2; AZU1; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; S100A12; MS4A2; FUT7; NAIP; IL18; PLD4; CD180; PROK2; IL23A; STAB1; PF4; PTGDR; ACKR1; PF4V1; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	32	381	8.3989501312336	0	0	0	0	0	0	0
down	TRAV27; NCR3; FCGR3B; IL18RAP; IL2RA; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGHA2; IGHD; HLA-DQA2; TRGV3; TRGC2; IGLV7-43; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; HLA-DQB2; IGKV4-1; IGHV4-34; CTSG; CD8B; GZMA; OSM; CTLA4; IGHV1-2; FCAR; HRH2; FCGR2B; CEACAM8; CNR2; CD79B; KIR2DL1; KIR3DL1; IGLV3-21; MS4A2; IRF8; RGS1; GPR65; LILRB2; FCGR1B; CYSLTR2; ICOS; IGLV8-61; IGLV5-45; CXCR1; TLR7; TRAV38-1; CXCR5; CD1C; CCR5; TLR8; PF4V1; CXCR3; IGLV4-69; TRAV2; IGLV3-9; TRDV2; PF4; CCR6; TRAV14DV4; TRAV9-2; CCR8; IGKV1-8; RAET1E; TRAV38-2DV8; TRAV19; CCR2;	GO:0006955~immune response	94	433	21.7090069284065	0	0	0	0	0	0	0
down	FCN1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	37	92	40.2173913043478	0	0	0	0	0	0	0
down	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C4BPA; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV3-21; IGHV5-51; IGHD; IGHV4-31; TRBC2; IGLL5; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV1-3; IGHA2;	GO:0006958~complement activation, classical pathway	51	161	31.6770186335404	0	0	0	0	0	0	0
down	TNFRSF13B; LILRA1; IFNG; IL2RA; CD3D; CD3G; CXCR1; KLRC1; CXCR3; CCR5; ADGRE1; ADGRF1; ADGRF2; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV25-1; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV14; TRBV15; TRBV30; TRBV4-2; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-6; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	51	268	19.0298507462687	0	0	0	0	0	0	0
down	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C4BPA; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; CD19; IGHV1-2; IGLV3-21;	GO:0030449~regulation of complement activation	38	113	33.6283185840708	0	0	0	0	0	0	0
down	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FCER1A; IGHV1-2; LILRA4; IGLV3-21; MS4A2;	GO:0038095~Fc-epsilon receptor signaling pathway	36	171	21.0526315789474	0	0	0	0	0	0	0
down	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGKV1-16; IGKV3-11; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	40	135	29.6296296296296	0	0	0	0	0	0	0
down	HP; S100A8; ELANE; S100A12; IRF8; CEBPE; STAB1; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGLL5; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV3-7; GSDMC; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; IGHV4-31; TRDC; IGKC; IGHV4-39; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHG4;	GO:0042742~defense response to bacterium	39	216	18.0555555555556	0	0	0	0	0	0	0
down	TRGV2; TRGV4; TRDV2; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; TRGV3; C4BPA; S100B; S100A8; RNASE3; DEFA4; KIR2DS4; NLRP6; LILRA4; S100A12; SIGLEC14; NAIP; SLAMF1; CD300E; CLEC10A; ZNF683; LILRA2; CLEC4C; RNASE6; PLD4; SIGLEC10; CD180; TRGV9; IL23A; TLR8; LYAR; TLR7; TRIM10; CD84; CLEC4A; TRDC; IGHV3-15; IGHV3-48; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV1-3; TRBC2; IGHV3-30; IGLC3; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLL5; IGLC2; IGHV3-74; IGHV4-31; IGHG3; BPI; IGHV3-11; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2;	GO:0045087~innate immune response	70	505	13.8613861386139	0	0	0	0	0	0	0
down	TRAV19; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV4-1; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; LILRB2; LILRB1; RAET1E; CD300LF; CD300A; SIGLEC7; BTNL8;	GO:0050776~regulation of immune response	66	216	30.5555555555556	0	0	0	0	0	0	0
down	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV3-11; IGHV3-21; IGHV4-39; IGHV1-2; IGHV2-5; IGLL5; IGLC3; IGHV3-30; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHG4; IGHV1-46; IGHV4-59; IGHV6-1; IGHG3; IGHV1-18; TRBC1; IGHA2; IGHV3-74; TRDC; IGHD; IGHV3-15; IGHV3-48; IGLC2; IGHV4-31; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	37	125	29.6	0	0	0	0	0	0	0
down	IGHG3; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGLC2; IGHV1-46; IGHV4-31; IGHV5-51; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	31	98	31.6326530612245	0	0	0	0	0	0	0
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.000107234593822	0.00276372794077617	0.175543030086619	0.182406044091227	0.158492729668921	0.175435795492797	0.0221553730051747
down	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.000107234593822	0.00276372794077617	0.175543030086619	0.182406044091227	0.158492729668921	0.175435795492797	0.0221553730051747
up	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00010762365807559	0.00223983219717166	0.363122222347058	0.380987749587607	0.238494026295519	0.362799351372831	0.0195968270053564
up	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.00010762365807559	0.00223983219717166	0.363122222347058	0.380987749587607	0.238494026295519	0.362799351372831	0.0195968270053564
up	HYAL2; AQP3; HAS2;	GO:0070295~renal water absorption	3	3	100	0.00010762365807559	0.00223983219717166	0.363122222347058	0.380987749587607	0.238494026295519	0.362799351372831	0.0195968270053564
up	BMP4; SOX9; SIX1;	GO:0072193~ureter smooth muscle cell differentiation	3	3	100	0.00010762365807559	0.00223983219717166	0.363122222347058	0.380987749587607	0.238494026295519	0.362799351372831	0.0195968270053564
up	NFIB; BMP4; SOX9; HMGA2; OSR1; WNT5B;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00010819528410066	0.00223983219717166	0.364618107419241	0.383011305716354	0.23921977314657	0.364618107419241	0.0195968270053564
down	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00011053223480039	0.00280619897605189	0.180720203898651	0.188015331395477	0.162040256217383	0.180720203898651	0.0224958412598702
down	VIL1; MS4A1; GZMA; FCGR2B; CD79B; RGS1; NLRP6;	GO:0009617~response to bacterium	7	92	7.60869565217391	0.00012027725068186	0.00296509570159209	0.196420277015701	0.204591603409854	0.172357300227114	0.196412750363487	0.0237696338686519
up	DSCAM; TSPAN12; TFAP2A; LHX1; FJX1;	GO:0010842~retina layer formation	5	23	21.7391304347826	0.00012302230271987	0.00248856543787638	0.414339115560547	0.435498951628366	0.256255456565505	0.414093070955107	0.0217730535524732
up	LDLR; APOE; PRRX1; HES1; FOXC2;	GO:0048844~artery morphogenesis	5	23	21.7391304347826	0.00012302230271987	0.00248856543787638	0.414339115560547	0.435498951628366	0.256255456565505	0.414093070955107	0.0217730535524732
up	DLL1; SOX2; PRRX1; JAG1; HES1;	GO:0097150~neuronal stem cell population maintenance	5	23	21.7391304347826	0.00012302230271987	0.00248856543787638	0.414339115560547	0.435498951628366	0.256255456565505	0.414093070955107	0.0217730535524732
down	GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.000123201908377	0.00299380637356115	0.201065514471267	0.20956644614928	0.175193113712097	0.201065514471267	0.0239997924299627
up	COL5A2; MGP; BMP7; SOX9; STC1; CDH11; ECM1; FOXC2;	GO:0001503~ossification	8	76	10.5263157894737	0.00012856778405956	0.00257135568119127	0.432502025576371	0.455129955570854	0.262461507932578	0.432502025576371	0.0224974051704301
down	OVOL1; POMC; PF4; CD3D; WNT1; OSM; GATA1; TAL1; SPI1; SPIB; IRF8; HHEX; IL18; IRF4; CEBPE; BATF; MACC1; NFE4; SKAP1; LILRB1; GRHL3; LMO7; ARNTL2; IL23A; GRHL1; EBF1; ZNF835; TBX21;	GO:0045944~positive regulation of transcription by RNA polymerase II	28	1138	2.46045694200351	0.00013463049346162	0.00322544323067932	0.219582334835917	0.229006469378232	0.185603963067146	0.219582334835917	0.0258567049340778
down	JCHAIN; IGKC; IGHG3; IGHA2; LTF;	GO:0001895~retina homeostasis	5	40	12.5	0.00013734853893487	0.0032448592323365	0.223878118463852	0.233629864728228	0.188030149801848	0.223878118463852	0.0260123529458221
up	APOE; BMP4; BMP7; HYAL2; CBLC; SPRY4;	GO:0043407~negative regulation of MAP kinase activity	6	39	15.3846153846154	0.00014025685318941	0.00278937786680069	0.471683797275997	0.496509260290523	0.274164884349543	0.471683797275997	0.0244049333594224
up	EFNA1; FOXA1; VASN; SFRP1; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.00014648143322881	0.00288080152016675	0.492470578515285	0.518544273630015	0.280365463199957	0.492324097082057	0.0252048207445018
up	MEIS2; ISL1; NKX3-2; HES1; MET;	GO:0031016~pancreas development	5	24	20.8333333333333	0.00014648143322881	0.00288080152016675	0.492470578515285	0.518544273630015	0.280365463199957	0.492324097082057	0.0252048207445018
down	FST; PTPRZ1; SERPINB12; FLT3; PLD4; TNFRSF13B;	GO:0002244~hematopoietic progenitor cell differentiation	6	66	9.09090909090909	0.00014952066441686	0.00344583911509991	0.24356916233508	0.254334650173094	0.199012004338853	0.24356916233508	0.0276235043921939
up	CLDN7; TYMS; CYP2E1; CSF3; HPGD; NQO1; FGFR2; CCND1; ADH7;	GO:0045471~response to ethanol	9	100	9	0.00014963755200991	0.00291561207923155	0.502782174753325	0.52971693411511	0.283546417031261	0.502782174753325	0.025509386642257
up	TLR3; IL33; LDLR; MDK; WNT5A; CX3CL1; HYAL2; TRPV4;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.00015168695628864	0.00291561207923155	0.509516486173554	0.536971825261798	0.285575544914456	0.509516486173554	0.025509386642257
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00015193294158288	0.00344583911509991	0.247346828896942	0.258437933632493	0.201159214655744	0.24719489595536	0.0276235043921939
down	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00015193294158288	0.00344583911509991	0.247346828896942	0.258437933632493	0.201159214655744	0.24719489595536	0.0276235043921939
up	DLL1; BMP4; WNT5A; SMO;	GO:0003323~type B pancreatic cell development	4	12	33.3333333333333	0.00015236955781294	0.00291561207923155	0.511656975135879	0.539388234657836	0.286264218620267	0.511352236020254	0.025509386642257
up	KRT14; KRT5; LAMB3; LAMC2;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.00015236955781294	0.00291561207923155	0.511656975135879	0.539388234657836	0.286264218620267	0.511352236020254	0.025509386642257
up	TERT; TBX3; GJA1; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00015236955781294	0.00291561207923155	0.511656975135879	0.539388234657836	0.286264218620267	0.511352236020254	0.025509386642257
down	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.00015516062236931	0.00347273971908154	0.252291171972499	0.263928218650197	0.204036218415643	0.252291171972499	0.0278391525775612
up	SNAI2; BMP7; FGFR2; WNT5A; SOX9; HMGA2;	GO:0001837~epithelial to mesenchymal transition	6	40	15	0.00015888202247071	0.00300771315265425	0.532890303366791	0.562442359546345	0.292756029050881	0.532890303366791	0.0263152009372526
up	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.00018584391543574	0.00346256558232916	0.623134648456057	0.657887460642541	0.319465690634048	0.622762960625185	0.0302948135120522
up	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.00018584391543574	0.00346256558232916	0.623134648456057	0.657887460642541	0.319465690634048	0.622762960625185	0.0302948135120522
up	BMP4; SOX9; FOXD1;	GO:0090184~positive regulation of kidney development	3	4	75	0.00018584391543574	0.00346256558232916	0.623134648456057	0.657887460642541	0.319465690634048	0.622762960625185	0.0302948135120522
up	TYMS; BCHE; IGFBP2; SDC1; MDK; ALDH3A1; WNT7B;	GO:0051384~response to glucocorticoid	7	60	11.6666666666667	0.00018924626194949	0.00350749616388067	0.633974977530805	0.669931767301208	0.322562558376152	0.633974977530805	0.030687921904291
up	TFPI; SOX9; HYAL2; SFRP1; HAS2; ADAMTS7; CCL26; CX3CL1;	GO:0071347~cellular response to interleukin-1	8	81	9.87654320987654	0.00019269747610595	0.00353010553294435	0.645343847478833	0.68214906541507	0.325658734619059	0.645343847478833	0.0308857366757729
up	BMP4; ISL1; JAG1; PPP1R13L;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.0001964493757034	0.00353010553294435	0.657516060479281	0.695430789990037	0.328758464881059	0.65692671235217	0.0308857366757729
up	MDK; CDH3; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.0001964493757034	0.00353010553294435	0.657516060479281	0.695430789990037	0.328758464881059	0.65692671235217	0.0308857366757729
up	MAL; SHROOM2; SHROOM3; VANGL2;	GO:0045176~apical protein localization	4	13	30.7692307692308	0.0001964493757034	0.00353010553294435	0.657516060479281	0.695430789990037	0.328758464881059	0.65692671235217	0.0308857366757729
up	MELTF; FBLN1; KANK1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	4	13	30.7692307692308	0.0001964493757034	0.00353010553294435	0.657516060479281	0.695430789990037	0.328758464881059	0.65692671235217	0.0308857366757729
up	GLI3; BMP4; GDNF; SOX9; LHX1; SIX1;	GO:0001658~branching involved in ureteric bud morphogenesis	6	42	14.2857142857143	0.00020197298497071	0.00359288626530812	0.675195688757086	0.714984366796316	0.333369445750069	0.674993715772116	0.0314350203019998
up	BMP4; BMP7; MDK; ISL1; PDPN; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	6	42	14.2857142857143	0.00020197298497071	0.00359288626530812	0.675195688757086	0.714984366796316	0.333369445750069	0.674993715772116	0.0314350203019998
down	FOLR2; CCR2; S100A12; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.00020672354325401	0.0044054068664129	0.335925757787778	0.351636747075083	0.243727057496486	0.335925757787778	0.0353158612050376
down	IL18RAP; IL18; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.0002071913870153	0.0044054068664129	0.336478812512854	0.352432549313032	0.244071453904028	0.336064429738823	0.0353158612050376
down	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0002071913870153	0.0044054068664129	0.336478812512854	0.352432549313032	0.244071453904028	0.336064429738823	0.0353158612050376
down	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0002071913870153	0.0044054068664129	0.336478812512854	0.352432549313032	0.244071453904028	0.336064429738823	0.0353158612050376
up	ADCY6; APOE; EFNB2; PMP22; CRMP1; KANK1; TRPV4;	GO:0010977~negative regulation of neuron projection development	7	61	11.4754098360656	0.00020775251575266	0.00367721952882223	0.694101155129665	0.735443905764446	0.338221095645344	0.694101155129665	0.0321728721723185
up	LRP5; LDLR; APOE; MALL; PCSK9; LIPG; CYP7B1; CYP39A1;	GO:0042632~cholesterol homeostasis	8	83	9.63855421686747	0.00022478532079195	0.0039393071069481	0.750558186124333	0.795740035603516	0.351364472993535	0.750558186124333	0.0344659390079819
down	IFNG; AZU1; FCGR2B; LYAR; SIRPG;	GO:0050766~positive regulation of phagocytosis	5	45	11.1111111111111	0.0002276181762626	0.00477998170151461	0.368969063721676	0.387178517822684	0.257812551819604	0.368969063721676	0.0383186333185979
down	IFNG; HLA-DQA2; HLA-DQB2; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	6	72	8.33333333333333	0.00023246447716673	0.00482222043488563	0.376592453010116	0.395422075660622	0.261057607858247	0.376592453010116	0.0386572393294479
up	ANXA1; IVL; SPRR1B; SPRR2E; SPRR1A;	GO:0018149~peptide cross-linking	5	27	18.5185185185185	0.00023767947535713	0.00410431874519147	0.793374088742111	0.841385342764251	0.361272802542842	0.792898729791396	0.035909665253461
up	BMP4; CDH1; SOX2; ISL1; PITX1;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00023767947535713	0.00410431874519147	0.793374088742111	0.841385342764251	0.361272802542842	0.792898729791396	0.035909665253461
up	RHOD; TRIP6; FERMT2; AJUBA; DLC1;	GO:0048041~focal adhesion assembly	5	27	18.5185185185185	0.00023767947535713	0.00410431874519147	0.793374088742111	0.841385342764251	0.361272802542842	0.792898729791396	0.035909665253461
down	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.00024463100403104	0.00495377783162873	0.396057595526267	0.416117337856813	0.26909908536622	0.395812964522236	0.0397118667236387
down	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.00024463100403104	0.00495377783162873	0.396057595526267	0.416117337856813	0.26909908536622	0.395812964522236	0.0397118667236387
up	WNT5A; TP63; INTU; VANGL2;	GO:0001736~establishment of planar polarity	4	14	28.5714285714286	0.00024902663211723	0.00421991489420502	0.830503818110972	0.881554277695005	0.369706846297499	0.830005764846737	0.0369210435779464
up	MEIS2; EPHA2; P2RY1; SOX2;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00024902663211723	0.00421991489420502	0.830503818110972	0.881554277695005	0.369706846297499	0.830005764846737	0.0369210435779464
up	COBL; BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00024902663211723	0.00421991489420502	0.830503818110972	0.881554277695005	0.369706846297499	0.830005764846737	0.0369210435779464
up	DLL1; WNT5A; TBX2; SMO; VANGL2; NDRG4; TBX3;	GO:0001947~heart looping	7	63	11.1111111111111	0.00024914186804769	0.00421991489420502	0.830503818110972	0.881962212888849	0.369726532182783	0.830140704334928	0.0369210435779464
up	PTN; FGFR2; LOX; LGR4; SLC24A3; TUFT1;	GO:0030282~bone mineralization	6	44	13.6363636363636	0.00025378157251176	0.00425775718811214	0.845346418036702	0.898386766691661	0.372551348447276	0.84509263646419	0.0372521348481407
up	FOSL1; SDC1; ALDH3A1; MMP19; DUOX2; DUOX1;	GO:0051591~response to cAMP	6	44	13.6363636363636	0.00025378157251176	0.00425775718811214	0.845346418036702	0.898386766691661	0.372551348447276	0.84509263646419	0.0372521348481407
down	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0002739866924355	0.00541920190503242	0.443036481668206	0.466051363832788	0.288781973827019	0.442762494975771	0.0434429300456496
down	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0002739866924355	0.00541920190503242	0.443036481668206	0.466051363832788	0.288781973827019	0.442762494975771	0.0434429300456496
up	FOSL1; HPGD; IGFBP2; ENDOU; COMT; IGFBP5; TEAD3; TFCP2L1;	GO:0007565~female pregnancy	8	86	9.30232558139535	0.00028101657586931	0.00468674854514104	0.935504181068965	0.994798678577391	0.38828255177279	0.935504181068965	0.0410054827199608
down	CD40LG; XCL1; TIGIT; IL23A;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.00028130096220091	0.00549991881268684	0.454301053954477	0.478492936703755	0.293678204537755	0.454301053954477	0.044089995616223
up	RHOD; MYO1B; SHROOM2; BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00028332321713564	0.00468674854514104	0.942899666627426	1	0.389385331852681	0.94261634341029	0.0410054827199608
up	SERPINE2; PTN; NTRK2; SYT12; PLK2; SHANK2;	GO:0060291~long-term synaptic potentiation	6	45	13.3333333333333	0.00028332321713564	0.00468674854514104	0.942899666627426	1	0.389385331852681	0.94261634341029	0.0410054827199608
up	HMGB3; INHA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.00029341080808897	0.00478651733011513	0.975884347703943	1	0.394344126071587	0.975297526087765	0.041878383655192
up	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00029341080808897	0.00478651733011513	0.975884347703943	1	0.394344126071587	0.975297526087765	0.041878383655192
up	LDLR; CRYAB; APOE;	GO:1905907~negative regulation of amyloid fibril formation	3	5	60	0.00029341080808897	0.00478651733011513	0.975884347703943	1	0.394344126071587	0.975297526087765	0.041878383655192
up	APOD; PLTP; VLDLR; SLCO2A1; STOML1; GULP1; CAV2;	GO:0006869~lipid transport	7	65	10.7692307692308	0.00029691862137393	0.00482152256726476	0.986660578825575	1	0.396089440912825	0.986660578825575	0.0421846528380214
up	PLXNB1; DCN; CSF3; KDR; SOX9; NTRK2; UNC5B; ROR1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	8	87	9.19540229885057	0.00030212978217214	0.00488374168442645	1	1	0.398700409525089	0.999609384753994	0.0427290227586713
up	APOE; SH3D19; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	4	15	26.6666666666667	0.0003110015958625	0.00500429840615119	1	1	0.403058068237804	0.999609384753994	0.0437838023189241
up	BMP7; IGSF9; BAIAP2; LAMC2; EGFLAM; NTN1;	GO:0016358~dendrite development	6	46	13.0434782608696	0.0003154964185793	0.00503088883680519	1	1	0.405302648808589	0.999609384753994	0.0440164483493644
up	DLL1; CXCL14; GJB2; SOX2; ROR1; SIX1;	GO:0048839~inner ear development	6	46	13.0434782608696	0.0003154964185793	0.00503088883680519	1	1	0.405302648808589	0.999609384753994	0.0440164483493644
up	ERBB2; GLI3; NTRK2; BOK; SOX9;	GO:0048709~oligodendrocyte differentiation	5	29	17.2413793103448	0.00031891768764791	0.00506263952589063	1	1	0.406938969438737	0.999609384753994	0.0442942427136449
up	EML1; KRT75; BMP4; HYAL2; DACT2; SFRP1; BVES;	GO:0002244~hematopoietic progenitor cell differentiation	7	66	10.6060606060606	0.00032341924057643	0.00511117906982408	1	1	0.409137420952011	0.999609384753994	0.0447189267799708
up	DCN; COL4A2; NPR1; HOXA5; PTN; EPHA2; SULF1; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0003482436502239	0.00545478991943632	1	1	0.420534382933908	0.999609384753994	0.0477252601943746
down	F13A1; CSTA; TGM4; EPB42;	GO:0018149~peptide cross-linking	4	27	14.8148148148148	0.00036620547131271	0.00707858530344245	0.591055630698729	0.622915506702936	0.341758252052178	0.591055630698729	0.0567453458181817
up	ERBB2; LHX1; LAMC2; NTN1; EGFLAM;	GO:0008045~motor neuron axon guidance	5	30	16.6666666666667	0.00036665266286495	0.00566790579275953	1	1	0.428892283849959	0.999609384753994	0.0495898618850209
up	APOD; NPR1; COMT; IGFBP5; NDRG4;	GO:0048662~negative regulation of smooth muscle cell proliferation	5	30	16.6666666666667	0.00036665266286495	0.00566790579275953	1	1	0.428892283849959	0.999609384753994	0.0495898618850209
up	LRP5; TFAP2A; FGFR2; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	5	30	16.6666666666667	0.00036665266286495	0.00566790579275953	1	1	0.428892283849959	0.999609384753994	0.0495898618850209
up	CNTN1; CNKSR3; PKP2; PRSS8;	GO:0010765~positive regulation of sodium ion transport	4	16	25	0.00038329303793183	0.00582342212136773	1	1	0.436396375876204	0.999609384753994	0.050950511398003
up	BMP7; STC1; CYP24A1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00038329303793183	0.00582342212136773	1	1	0.436396375876204	0.999609384753994	0.050950511398003
up	INHA; BMP4; BMP7; CDKN2B;	GO:0042326~negative regulation of phosphorylation	4	16	25	0.00038329303793183	0.00582342212136773	1	1	0.436396375876204	0.999609384753994	0.050950511398003
up	PTN; MDK; HAS2; ANXA1;	GO:0044849~estrous cycle	4	16	25	0.00038329303793183	0.00582342212136773	1	1	0.436396375876204	0.999609384753994	0.050950511398003
down	CSTA; DSG1; PKP1; LIPN; KRT80; CERS3; SPINK5;	GO:0070268~cornification	7	113	6.19469026548673	0.00039401841910535	0.00753062169548554	0.635551710016942	0.670225330898213	0.355404614033032	0.635551710016942	0.060369087044612
up	MID1; LHX1; SIX1; SOSTDC1; SHROOM3;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00041959281403325	0.00634768616101589	1	1	0.451143320719437	0.999609384753994	0.0555374227314
up	BMP4; BMP7; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.00043429056040178	0.00643258821682978	1	1	0.456439378982275	0.999609384753994	0.056280251101438
up	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.00043429056040178	0.00643258821682978	1	1	0.456439378982275	0.999609384753994	0.056280251101438
up	JUP; DSG2; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00043429056040178	0.00643258821682978	1	1	0.456439378982275	0.999609384753994	0.056280251101438
up	MYO1C; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.00043429056040178	0.00643258821682978	1	1	0.456439378982275	0.999609384753994	0.056280251101438
up	SNAI2; FBLN1; KDF1;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00043429056040178	0.00643258821682978	1	1	0.456439378982275	0.999609384753994	0.056280251101438
down	EREG; FST; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00044591512561376	0.00835515789347538	0.718815182489382	0.758501628669007	0.378581941646083	0.718815182489382	0.066978965952448
down	SCEL; GJB5; FABP5; CERS3; GRHL3; GRHL1;	GO:0008544~epidermis development	6	82	7.31707317073171	0.00044698375561802	0.00835515789347538	0.720090830300637	0.76031936830626	0.379042224764085	0.720090830300637	0.066978965952448
up	LRP5; SDC1; WNT5A; WNT7B; SFRP1; FZD10; FZD6;	GO:0060070~canonical Wnt signaling pathway	7	70	10	0.00044900345241893	0.00662280092317935	1	1	0.461612172754022	0.999609384753994	0.0579444675124979
down	MMP8; SCIMP; LILRB2; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	5	53	9.43396226415094	0.0004578326665996	0.00846492789006435	0.737110593225356	0.77877336588592	0.383959570845137	0.737110593225356	0.0678589350634895
up	KRT16; SERPINB5; RIPK4; SOX9;	GO:0002009~morphogenesis of an epithelium	4	17	23.5294117647059	0.00046683502947486	0.00677293444402059	1	1	0.468057885155528	0.999609384753994	0.0592580215543346
up	SCARA3; MATN3; MATN2; VWA1;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.00046683502947486	0.00677293444402059	1	1	0.468057885155528	0.999609384753994	0.0592580215543346
up	GJA1; EPHA2; LGR4; LRP5;	GO:0046849~bone remodeling	4	17	23.5294117647059	0.00046683502947486	0.00677293444402059	1	1	0.468057885155528	0.999609384753994	0.0592580215543346
up	BMP4; MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.00046683502947486	0.00677293444402059	1	1	0.468057885155528	0.999609384753994	0.0592580215543346
down	ORM1; BPI; NCKAP1L; SLAMF1;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.00046800044072226	0.00855987902869425	0.753012709122117	0.796068749668565	0.388440365799476	0.753012709122117	0.0686201090786932
up	EML1; MID1; OBSL1; CRMP1; MARK1; CAMSAP3; PARD3; TUBB6; CALML3;	GO:0000226~microtubule cytoskeleton organization	9	118	7.6271186440678	0.00046893151783555	0.006775581931175	1	1	0.468835164507211	0.999609384753994	0.0592811850519526
up	DLL1; EPN2; JAG1; ELF3; HES1; TP63;	GO:0045747~positive regulation of Notch signaling pathway	6	50	12	0.00047380556483767	0.00681817764034697	1	1	0.470488925883807	0.999609384753994	0.0596538650879247
up	PLXNB1; PLXNA2; MET; SEMA6D; SEMA3F;	GO:0071526~semaphorin-plexin signaling pathway	5	32	15.625	0.0004780960241546	0.00685206447573808	1	1	0.472018191202534	0.999609384753994	0.0599503491065745
up	FGD1; NTRK2; NGEF; BVES; AJUBA; PLXNB1; PLXNA2;	GO:0043087~regulation of GTPase activity	7	71	9.85915492957746	0.00048578618081007	0.00693420596801481	1	1	0.47476468364093	0.999609384753994	0.0606690246467072
up	TBX3; TFAP2A; MSX2; OSR1; TP63;	GO:0035115~embryonic forelimb morphogenesis	5	33	15.1515151515152	0.00054252917259334	0.007591119648144	1	1	0.495025005108703	0.999609384753994	0.0664165193756425
up	HOXD8; FGFR2; HOXC8; NKX3-2; HYAL2;	GO:0048705~skeletal system morphogenesis	5	33	15.1515151515152	0.00054252917259334	0.007591119648144	1	1	0.495025005108703	0.999609384753994	0.0664165193756425
up	DLL1; NOS1; CX3CL1; HES1; HES2;	GO:0050767~regulation of neurogenesis	5	33	15.1515151515152	0.00054252917259334	0.007591119648144	1	1	0.495025005108703	0.999609384753994	0.0664165193756425
up	NGFR; NTRK2; ROBO1; PLXNA2; PLXNB1;	GO:0050772~positive regulation of axonogenesis	5	33	15.1515151515152	0.00054252917259334	0.007591119648144	1	1	0.495025005108703	0.999609384753994	0.0664165193756425
up	BMP4; LHX1; HES1; ZDHHC16;	GO:0021537~telencephalon development	4	18	22.2222222222222	0.00056257391071956	0.00780984958410692	1	1	0.50224754221059	0.999609384753994	0.0683302398415642
up	PLXNA2; BMP7; ISL1; SIX1;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.00056257391071956	0.00780984958410692	1	1	0.50224754221059	0.999609384753994	0.0683302398415642
up	LRP5; CYP7B1; LDLR; APOE; CYP11A1; VLDLR; PCSK9;	GO:0008203~cholesterol metabolic process	7	73	9.58904109589041	0.00056654083119234	0.0078341974313316	1	1	0.503654798929992	0.999609384753994	0.0685432649738118
up	ZBTB7C; SNAI2; LRP5; SFRP1; CCDC3; WNT5B;	GO:0045600~positive regulation of fat cell differentiation	6	52	11.5384615384615	0.00057317729948613	0.00789512700459506	1	1	0.506064776648469	0.999609384753994	0.0690763523668148
up	TBX3; HOXD8; WNT5A;	GO:0008595~anterior/posterior axis specification, embryo	3	7	42.8571428571429	0.00061221030297886	0.00825462935546128	1	1	0.517581121501553	0.999609384753994	0.0722217243222855
up	IGSF3; FGFR2; SOX9;	GO:0032808~lacrimal gland development	3	7	42.8571428571429	0.00061221030297886	0.00825462935546128	1	1	0.517581121501553	0.999609384753994	0.0722217243222855
up	IL33; CX3CL1; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00061221030297886	0.00825462935546128	1	1	0.517581121501553	0.999609384753994	0.0722217243222855
up	LHX1; OSR1; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00061221030297886	0.00825462935546128	1	1	0.517581121501553	0.999609384753994	0.0722217243222855
up	BMP4; HOXA5; EDN2; FGFR2; IGFBP5;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.00061326766115432	0.00825462935546128	1	1	0.517874698833204	0.999609384753994	0.0722217243222855
up	RBFOX2; DSCAM; LRP4; VLDLR; BTBD3;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.00061326766115432	0.00825462935546128	1	1	0.517874698833204	0.999609384753994	0.0722217243222855
up	TNFRSF21; NFASC; ERBB2; MAL; PMP22; MALL;	GO:0042552~myelination	6	53	11.3207547169811	0.00062856247552667	0.00842845137638039	1	1	0.522095465928111	0.999609384753994	0.0737425347106595
up	NKX2-8; COBL; PTN; AK4; HES1; PCSK9; MET;	GO:0001889~liver development	7	75	9.33333333333333	0.00065761140632991	0.008784695767577	1	1	0.530034793501913	0.999609384753994	0.0768594019986305
up	LRP4; MDK; SOX9; SFRP1;	GO:0030279~negative regulation of ossification	4	19	21.0526315789474	0.00067146542459339	0.00883638514148933	1	1	0.533815012551752	0.999609384753994	0.0773116446799591
up	EPHA2; WNT5A; TP63; VANGL2;	GO:0036342~post-anal tail morphogenesis	4	19	21.0526315789474	0.00067146542459339	0.00883638514148933	1	1	0.533815012551752	0.999609384753994	0.0773116446799591
up	ADCY6; NPR1; P2RY1; FOXC2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.00067146542459339	0.00883638514148933	1	1	0.533815012551752	0.999609384753994	0.0773116446799591
up	CSF3; BAIAP2L1; BAIAP2L2; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	4	19	21.0526315789474	0.00067146542459339	0.00883638514148933	1	1	0.533815012551752	0.999609384753994	0.0773116446799591
down	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.00067482451704592	0.0119570469114075	1	1	0.474797976032078	0.97926915095487	0.0958534414527811
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.00067482451704592	0.0119570469114075	1	1	0.474797976032078	0.97926915095487	0.0958534414527811
down	CCR2; SPINK5; TBX21;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.00067482451704592	0.0119570469114075	1	1	0.474797976032078	0.97926915095487	0.0958534414527811
down	EREG; OSM; CD19; IL18; TRAT1; EPGN; PIK3R5; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	8	165	4.84848484848485	0.00072983840539619	0.0121711287017543	1	1	0.493370762047831	0.97926915095487	0.0975696240946285
up	ERBB2; MET; FGFR2; EPHA2; KDR; ROR1; TYRO3; EFEMP1; NTRK2;	GO:0018108~peptidyl-tyrosine phosphorylation	9	127	7.08661417322835	0.00076924894825591	0.0100857084326887	1	1	0.555397740640773	0.999609384753994	0.0882422726271385
up	TERT; FGFR2; KANK1; SULF1; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	5	36	13.8888888888889	0.00077520198170488	0.0100890257913063	1	1	0.556478441876976	0.999609384753994	0.0882712969902246
up	GDNF; SOX2; ISL1; DLX2; PPP1R13L;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00077520198170488	0.0100890257913063	1	1	0.556478441876976	0.999609384753994	0.0882712969902246
up	PRRX1; NKX3-2; SIX1; OSR1;	GO:0042474~middle ear morphogenesis	4	20	20	0.00079447200828619	0.0102458562633153	1	1	0.559868375279799	0.999609384753994	0.0896434442577791
up	DDR1; POSTN; PAK6; FLRT3;	GO:1990138~neuron projection extension	4	20	20	0.00079447200828619	0.0102458562633153	1	1	0.559868375279799	0.999609384753994	0.0896434442577791
down	HBG2; HBA1; HBM;	GO:0015671~oxygen transport	3	14	21.4285714285714	0.00081271961284379	0.0131660577280694	1	1	0.516076954155809	0.97926915095487	0.105545453902789
down	MMP8; FCGR2B; IL23A;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.00081271961284379	0.0131660577280694	1	1	0.516076954155809	0.97926915095487	0.105545453902789
down	P2RY10; GPR171; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	3	14	21.4285714285714	0.00081271961284379	0.0131660577280694	1	1	0.516076954155809	0.97926915095487	0.105545453902789
up	SPINT1; FZD6; COBL; BMP4; SHROOM3; DLC1; VANGL2;	GO:0001843~neural tube closure	7	78	8.97435897435897	0.00081556762628143	0.0102458562633153	1	1	0.563083455131491	0.999609384753994	0.0896434442577791
up	ANXA1; PDLIM4; CXADR; SYDE1; TRPV4; PARVA;	GO:0031532~actin cytoskeleton reorganization	6	56	10.7142857142857	0.00081986270421519	0.0102458562633153	1	1	0.563794374691299	0.999609384753994	0.0896434442577791
up	FGFR2; MSX2; ECM1;	GO:0003416~endochondral bone growth	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	GJA1; GJB2; GJC1;	GO:0016264~gap junction assembly	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	MAOA; COMT; MOXD1;	GO:0042420~dopamine catabolic process	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	NGFR; SOX2; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	APOE; PC; CAV2;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	NRP2; SLIT3; SEMA3F;	GO:0048846~axon extension involved in axon guidance	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	SCNN1A; SCNN1B; TRPV4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	TERT; PTN; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	MMP2; MSX2; SFRP1;	GO:0060346~bone trabecula formation	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
up	BMP4; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	3	8	37.5	0.00083066687784505	0.0102458562633153	1	1	0.565484723353151	0.999609384753994	0.0896434442577791
down	ELANE; KEL; CCR2; RYR2; ATP13A4; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	6	94	6.38297872340426	0.0008797663141733	0.0140607298655702	1	1	0.533138386389021	0.97926915095487	0.112717576249281
up	FZD6; NTN1; TFAP2A; FGFR2; PRRX1; SIX1;	GO:0042472~inner ear morphogenesis	6	57	10.5263157894737	0.00089268816295973	0.01097262533638	1	1	0.574940819599099	0.999609384753994	0.096002120508472
down	CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	4	35	11.4285714285714	0.00089274475336953	0.0140607298655702	1	1	0.536332353328036	0.97926915095487	0.112717576249281
down	LTF; DEFA4; DEFA3; S100A12;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.00089274475336953	0.0140607298655702	1	1	0.536332353328036	0.97926915095487	0.112717576249281
down	TRAV27; RNASE2; RNASE3; DEFA4; DEFA3; RNASE6;	GO:0050830~defense response to Gram-positive bacterium	6	95	6.31578947368421	0.00092671876586281	0.0144619139516756	1	1	0.544333180218007	0.97926915095487	0.115933660922547
up	SNAI2; EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.00093256023655685	0.0112366310518884	1	1	0.581127270625677	0.999609384753994	0.0983119695863519
up	FZD6; WNT5A; FZD10; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	4	21	19.047619047619	0.00093256023655685	0.0112366310518884	1	1	0.581127270625677	0.999609384753994	0.0983119695863519
up	FOXA1; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.00093256023655685	0.0112366310518884	1	1	0.581127270625677	0.999609384753994	0.0983119695863519
up	ANXA1; KDR; FOXC2; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00093256023655685	0.0112366310518884	1	1	0.581127270625677	0.999609384753994	0.0983119695863519
up	LOX; EPHA2; KDR; SOX9; TYRO3;	GO:0043491~protein kinase B signaling	5	38	13.1578947368421	0.00096705417141973	0.0115654451581955	1	1	0.586556383252247	0.999609384753994	0.101188842758529
up	RAB13; MARVELD2; PARD3; MARVELD3; PARD6G;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.00096705417141973	0.0115654451581955	1	1	0.586556383252247	0.999609384753994	0.101188842758529
down	ELANE; TLR8; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.00096728174910032	0.0148165452263142	1	1	0.554252442234486	0.97926915095487	0.118776555859127
down	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.00096728174910032	0.0148165452263142	1	1	0.554252442234486	0.97926915095487	0.118776555859127
down	ASS1; FASLG; AIF1; IRF8; XCL1; XCL2;	GO:0071346~cellular response to interferon-gamma	6	96	6.25	0.00097557499432521	0.0148165452263142	1	1	0.556077746765371	0.97926915095487	0.118776555859127
up	CRYAB; MYL6B; GJA1; GJC1; MYL7; CALD1; MYOM3; NOS1;	GO:0006936~muscle contraction	8	106	7.54716981132075	0.00101921981604791	0.0121482765953185	1	1	0.594367717437589	0.999609384753994	0.106288174244613
up	NGFR; MAL; NHLH2; NDN; TAGLN3; TBX2; SMO; SOX9; TBX3;	GO:0007417~central nervous system development	9	133	6.76691729323308	0.00104510251903345	0.0124149762328134	1	1	0.598160511691337	0.999609384753994	0.108621593089551
up	GPR37; ADCY6; EDNRA; P2RY1; GNAI1; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	6	59	10.1694915254237	0.00105318892732797	0.0124691933202041	1	1	0.599264499649618	0.999609384753994	0.109095951339991
up	TFAP2A; BMP4; BMP7; PTN; OSR1;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.00107521458033588	0.0125616598769705	1	1	0.602526866614577	0.999609384753994	0.109904963336077
up	BMP7; FGFR2; LHX1; SIM2;	GO:0009880~embryonic pattern specification	4	22	18.1818181818182	0.00108669841128084	0.0125616598769705	1	1	0.604204316672147	0.999609384753994	0.109904963336077
up	APOE; DCN; NR2F2; STC1;	GO:0010596~negative regulation of endothelial cell migration	4	22	18.1818181818182	0.00108669841128084	0.0125616598769705	1	1	0.604204316672147	0.999609384753994	0.109904963336077
up	APOD; PTN; MDK; SOX2;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.00108669841128084	0.0125616598769705	1	1	0.604204316672147	0.999609384753994	0.109904963336077
up	KLK8; TNFRSF21; TMEM98;	GO:0031642~negative regulation of myelination	3	9	33.3333333333333	0.00109293537912625	0.0125616598769705	1	1	0.605192229155333	0.999609384753994	0.109904963336077
up	FBN1; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.00109293537912625	0.0125616598769705	1	1	0.605192229155333	0.999609384753994	0.109904963336077
up	LOX; MFAP4; THSD4;	GO:0048251~elastic fiber assembly	3	9	33.3333333333333	0.00109293537912625	0.0125616598769705	1	1	0.605192229155333	0.999609384753994	0.109904963336077
up	BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051764~actin crosslink formation	3	9	33.3333333333333	0.00109293537912625	0.0125616598769705	1	1	0.605192229155333	0.999609384753994	0.109904963336077
up	WNT5A; LHX1; FOXA2;	GO:0090009~primitive streak formation	3	9	33.3333333333333	0.00109293537912625	0.0125616598769705	1	1	0.605192229155333	0.999609384753994	0.109904963336077
down	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.00113925154810501	0.0170322387792811	1	1	0.592410805014607	0.97926915095487	0.136538621512144
up	EPHA2; KDR; GJC1; NTRK2; HAS2; SMO;	GO:0001570~vasculogenesis	6	60	10	0.00114129841913257	0.0130750692677324	1	1	0.612061560018388	0.999609384753994	0.114396904753113
up	ADCY6; EDNRA; ADORA2B; CAP2; LGR4;	GO:0007190~activation of adenylate cyclase activity	5	40	12.5	0.00119208429633066	0.013439421684747	1	1	0.619553710213026	0.999609384753994	0.117584711096032
up	MMP2; FBLN1; STC1; EMP2; DDR1;	GO:0007566~embryo implantation	5	40	12.5	0.00119208429633066	0.013439421684747	1	1	0.619553710213026	0.999609384753994	0.117584711096032
up	GLI3; CDH1; JUP; HYAL2; SMO;	GO:0042307~positive regulation of protein import into nucleus	5	40	12.5	0.00119208429633066	0.013439421684747	1	1	0.619553710213026	0.999609384753994	0.117584711096032
up	KRT8; KRT19; FHOD3; MYOM3; CSRP1;	GO:0045214~sarcomere organization	5	40	12.5	0.00119208429633066	0.013439421684747	1	1	0.619553710213026	0.999609384753994	0.117584711096032
up	TNFRSF21; NGFR; GRIK2; TP63; BOK;	GO:0051402~neuron apoptotic process	5	40	12.5	0.00119208429633066	0.013439421684747	1	1	0.619553710213026	0.999609384753994	0.117584711096032
down	CD3G; SLA; GRAP; SKAP1; FCRL2;	GO:0009967~positive regulation of signal transduction	5	67	7.46268656716418	0.00123191247175591	0.0174623592871401	1	1	0.610178529116602	0.97926915095487	0.139986674465617
up	GLI3; CX3CL1; DMRTA2; SMO;	GO:0002052~positive regulation of neuroblast proliferation	4	23	17.3913043478261	0.00125785429113068	0.014002528901266	1	1	0.628927145565339	0.999609384753994	0.122511470663792
up	BAIAP2L2; A4GALT; BAIAP2L1; BAIAP2;	GO:0007009~plasma membrane organization	4	23	17.3913043478261	0.00125785429113068	0.014002528901266	1	1	0.628927145565339	0.999609384753994	0.122511470663792
up	CYP7B1; CYP11A1; CYP51A1; CYP39A1;	GO:0016125~sterol metabolic process	4	23	17.3913043478261	0.00125785429113068	0.014002528901266	1	1	0.628927145565339	0.999609384753994	0.122511470663792
up	PTN; MDK; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	4	23	17.3913043478261	0.00125785429113068	0.014002528901266	1	1	0.628927145565339	0.999609384753994	0.122511470663792
down	ASS1; IFNG; MMP8; AIF1;	GO:0045429~positive regulation of nitric oxide biosynthetic process	4	39	10.2564102564103	0.00129364783426766	0.0181859088106553	1	1	0.620020118295902	0.97926915095487	0.14578699559878
down	GATA1; NCKAP1L; LYAR;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.00132933894962561	0.0185344717484686	1	1	0.626001019758563	0.97926915095487	0.148581243827447
up	DCN; HPGD; GJA1; FGFR2; COMT; GJB2; BDKRB1; GNG12; NOS1;	GO:0032496~response to lipopolysaccharide	9	138	6.52173913043478	0.00133176485506559	0.0147152441920957	1	1	0.639606229851617	0.999609384753994	0.128747187016159
up	KRT19; GLI3; IGFBP2; COMT; CCND1; CITED4;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.00133434841402902	0.0147152441920957	1	1	0.640181790116789	0.999609384753994	0.128747187016159
down	PF4; ADGRF1; GPR65; ADGRE1; ADGRE3; PTGDR;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	6	103	5.8252427184466	0.00137524619617779	0.0189558023330271	1	1	0.633065945812649	0.97926915095487	0.151958832526269
up	MMP2; EFNA1; EPHA2; EFNB2; EFNB3; ARHGEF28; NGEF;	GO:0048013~ephrin receptor signaling pathway	7	86	8.13953488372093	0.00138570750263589	0.0150404670403434	1	1	0.647366492869648	0.999609384753994	0.131592639413596
down	IFNG; OSM; FLT3; IL18; IL23A;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00139298958943468	0.0189558023330271	1	1	0.636025126961228	0.97926915095487	0.151958832526269
up	HOXC11; GDNF; SIX1;	GO:0001759~organ induction	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	BMP4; FGFR2; VANGL2;	GO:0003149~membranous septum morphogenesis	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	GLI3; SOX9; ANXA1;	GO:0030850~prostate gland development	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	EMP2; PMP22; LPAR3;	GO:0032060~bleb assembly	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	CDH13; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	WNT5A; LHX1; TYRO3;	GO:0060068~vagina development	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	PDLIM4; PDLIM3; PDLIM1;	GO:0061061~muscle structure development	3	10	30	0.00140207743596421	0.0150404670403434	1	1	0.649881514209468	0.999609384753994	0.131592639413596
up	APOE; RBP1; SDC1; GPC1; ADH7; GPC6;	GO:0001523~retinoid metabolic process	6	63	9.52380952380952	0.00143974437612393	0.0152906121312248	1	1	0.655105642137197	0.999609384753994	0.13378121857521
up	C3; MSMO1; ACOT11; ECHDC3; CYP4F11; ACOT7;	GO:0006631~fatty acid metabolic process	6	63	9.52380952380952	0.00143974437612393	0.0152906121312248	1	1	0.655105642137197	0.999609384753994	0.13378121857521
up	LRP5; SOX2; SOX9; HES1; SFRP1; VANGL2;	GO:0035019~somatic stem cell population maintenance	6	63	9.52380952380952	0.00143974437612393	0.0152906121312248	1	1	0.655105642137197	0.999609384753994	0.13378121857521
down	IFNG; XCL1; LILRB1; BATF3; TLR8; TBX21;	GO:0009615~response to virus	6	104	5.76923076923077	0.00144122191532925	0.0194564958569449	1	1	0.643783955582505	0.97926915095487	0.155972632734316
up	WNT5A; SOX9; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.00144699295592099	0.0152906121312248	1	1	0.656453940526311	0.999609384753994	0.13378121857521
up	ANXA1; KANK1; DUOX2; DUOX1;	GO:0090303~positive regulation of wound healing	4	24	16.6666666666667	0.00144699295592099	0.0152906121312248	1	1	0.656453940526311	0.999609384753994	0.13378121857521
up	TYMS; FOSL1; PTN; GJB2; DSG2;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.00145364120577207	0.0153151484179558	1	1	0.657110455783837	0.999609384753994	0.133995892409718
up	NGFR; F3; XDH; DLC1; BCL2L10; BOK; ROBO1;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	7	87	8.04597701149425	0.00147459068090716	0.0154897656095292	1	1	0.659917295872034	0.999609384753994	0.135523659936119
down	FUT3; FUT7; SIRPG;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.0015382239313827	0.0202830923045114	1	1	0.659203545846201	0.97926915095487	0.162599027594096
down	KIR3DL1; IL18; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.0015382239313827	0.0202830923045114	1	1	0.659203545846201	0.97926915095487	0.162599027594096
down	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.0015382239313827	0.0202830923045114	1	1	0.659203545846201	0.97926915095487	0.162599027594096
up	SNAI2; ERBB2; SOX9; GAREM1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	5	43	11.6279069767442	0.00159918402230941	0.0167488504111695	1	1	0.675008050360014	0.999609384753994	0.146539693670242
up	EDNRA; EMP2; OCA2; KANK1; CSPG4; FAM83A; RHBDF1; TP63; LIPG;	GO:0008283~cell population proliferation	9	142	6.33802816901408	0.00160401251594988	0.0167498652108041	1	1	0.675634769441796	0.999609384753994	0.146548572394688
up	SDC1; GPC1; HYAL2; GPC6;	GO:0006027~glycosaminoglycan catabolic process	4	25	16	0.00165507479956362	0.0169825066390006	1	1	0.68189081742021	0.999609384753994	0.148584007829719
up	PYCR1; FOLH1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	4	25	16	0.00165507479956362	0.0169825066390006	1	1	0.68189081742021	0.999609384753994	0.148584007829719
up	GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	4	25	16	0.00165507479956362	0.0169825066390006	1	1	0.68189081742021	0.999609384753994	0.148584007829719
up	FGFR2; ISL1; FOXC2; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	4	25	16	0.00165507479956362	0.0169825066390006	1	1	0.68189081742021	0.999609384753994	0.148584007829719
up	PTPRF; SPARCL1; FLRT3; GPC6;	GO:0099560~synaptic membrane adhesion	4	25	16	0.00165507479956362	0.0169825066390006	1	1	0.68189081742021	0.999609384753994	0.148584007829719
up	APOE; CDH1; GDNF; RAB13; CNTN1; NRTN; FLRT3; CAMSAP3;	GO:0031175~neuron projection development	8	115	6.95652173913043	0.00165996764571463	0.0169834840052884	1	1	0.682246702388714	0.999609384753994	0.148592559040871
down	MS4A1; CD40LG; FLT3; HHEX; CD79B;	GO:0030183~B cell differentiation	5	72	6.94444444444444	0.00166299258077407	0.0214759075844434	1	1	0.678951080008096	0.97926915095487	0.172161208828817
down	CA4; HBA1; SLC26A9; SLC39A8;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.00166656072965699	0.0214759075844434	1	1	0.67995677770005	0.97926915095487	0.172161208828817
down	POMC; NMU; NMUR1; PROK2; SSTR3; CYSLTR2;	GO:0007218~neuropeptide signaling pathway	6	108	5.55555555555556	0.00172952127183368	0.0215571039368535	1	1	0.690064232078284	0.97926915095487	0.172812117859248
up	BMP4; BMP7; OSR1;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	BMP4; WNT5A; ISL1;	GO:0003139~secondary heart field specification	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	SOX9; HMGA2; SFRP1;	GO:0010564~regulation of cell cycle process	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	FGFR2; KDF1; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	COL4A1; DDR1; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	NPR1; BDKRB2; HRH1;	GO:0043114~regulation of vascular permeability	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	PTN; JAG1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	PLXNA2; FGFR2; SOX9;	GO:0060174~limb bud formation	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	BMP7; FGFR2; LAMA1;	GO:0060445~branching involved in salivary gland morphogenesis	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	JUP; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
up	WNT5A; FOXA1; FOXA2;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	3	11	27.2727272727273	0.00176094924487136	0.0172760292094045	1	1	0.692343934750363	0.999609384753994	0.151152106922873
down	GATA1; TAL1; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.00176655721561403	0.0215571039368535	1	1	0.695976998884859	0.97926915095487	0.172812117859248
up	TLL1; MMP2; MMP10; KLK7; MMP19; KLK5;	GO:0022617~extracellular matrix disassembly	6	66	9.09090909090909	0.00179421574564265	0.0172760292094045	1	1	0.69585837096737	0.999609384753994	0.151152106922873
down	IL2RA; CTLA4; LILRB2; LILRB1;	GO:0042130~negative regulation of T cell proliferation	4	43	9.30232558139535	0.00180583713296079	0.0217853117955057	1	1	0.702147965115301	0.97926915095487	0.174641541861717
up	TM7SF3; HSPB8; HSPA2; HSPA1B;	GO:0034620~cellular response to unfolded protein	4	26	15.3846153846154	0.00188305364803931	0.0175421313527873	1	1	0.704262064366703	0.999609384753994	0.153480298149078
up	COL5A2; LOX; FMOD; FOXC2; SERPINH1;	GO:0030199~collagen fibril organization	5	45	11.1111111111111	0.00192196469932115	0.0178476130478041	1	1	0.707327001848939	0.999609384753994	0.156153030480592
up	BMP4; FGFR2; LHX1; PPP1R13L; NDN; ETNK2;	GO:0009791~post-embryonic development	6	67	8.95522388059701	0.00192592886561049	0.0178476130478041	1	1	0.707859467222207	0.999609384753994	0.156153030480592
down	CD3G; CD8B; IRF4; TREML2;	GO:0042110~T cell activation	4	44	9.09090909090909	0.00195297489876145	0.0232308412782743	1	1	0.724553687440498	0.97926915095487	0.186229601745688
up	NFIB; C3; CYP2E1; ADH7; STOX2; BAIAP2L1; BAIAP2;	GO:0009617~response to bacterium	7	92	7.60869565217391	0.00198766159727637	0.0183237553498915	1	1	0.712823418605252	0.999609384753994	0.160318913235435
up	LRP4; CSF3; GHR; EFNA1; KITLG; CNTN1; CSPG4;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	7	92	7.60869565217391	0.00198766159727637	0.0183237553498915	1	1	0.712823418605252	0.999609384753994	0.160318913235435
down	NMU; KCNQ1; RYR2;	GO:0010460~positive regulation of heart rate	3	20	15	0.0020149609626956	0.0236375765347946	1	1	0.729415868495807	0.97926915095487	0.189490187272073
down	NEFH; NCKAP1L; PARVG;	GO:0030031~cell projection assembly	3	20	15	0.0020149609626956	0.0236375765347946	1	1	0.729415868495807	0.97926915095487	0.189490187272073
up	SPINT1; C3; TFPI; TFPI2; SERPINB7; SERPINE2; SERPINB5; SERPINA10; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	9	148	6.08108108108108	0.00209429651433712	0.0191112487912709	1	1	0.7212153062264	0.999609384753994	0.167208881492009
up	DLL1; PLXNA2; WNT5A; FOXC2; TBX18;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00210007790389954	0.0191112487912709	1	1	0.721848784756243	0.999609384753994	0.167208881492009
up	TBX3; ISL1; TBX2; HES1; SIX1;	GO:0003151~outflow tract morphogenesis	5	46	10.8695652173913	0.00210007790389954	0.0191112487912709	1	1	0.721848784756243	0.999609384753994	0.167208881492009
up	MYO1D; NR2F2; SOX2; POU3F1; DLC1;	GO:0030900~forebrain development	5	46	10.8695652173913	0.00210007790389954	0.0191112487912709	1	1	0.721848784756243	0.999609384753994	0.167208881492009
up	GJA1; IGFBP2; GJB2; TRIML2; AQP3;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00210007790389954	0.0191112487912709	1	1	0.721848784756243	0.999609384753994	0.167208881492009
up	LHX1; HYAL2; POSTN; SFRP1;	GO:0044344~cellular response to fibroblast growth factor stimulus	4	27	14.8148148148148	0.00213187499572465	0.0192240528203201	1	1	0.723711462412909	0.999609384753994	0.168195830891868
up	CCBE1; PDPN; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	EDN2; PTN; MDK;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	CYP11A1; CYP24A1; LGMN;	GO:0042359~vitamin D metabolic process	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	BMP4; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	MET; BCAR1; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	F3; KDR; CDH13;	GO:0050927~positive regulation of positive chemotaxis	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	SPINT1; FOSL1; NR2F2;	GO:0060674~placenta blood vessel development	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	NFIB; GDNF; SMO;	GO:0071679~commissural neuron axon guidance	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	SEMA3F; PLXNA2; PLXNB1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
up	UBE2C; PLK1; CDC20;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.00217220935822826	0.0192240528203201	1	1	0.725802015481854	0.999609384753994	0.168195830891868
down	HP; HBG2; HBA1; HBM; LOXHD1;	GO:0098869~cellular oxidant detoxification	5	77	6.49350649350649	0.00219556675388177	0.0255798564955678	1	1	0.74456679500708	0.97926915095487	0.205060438010762
up	MELTF; IGFBP4; IGFBP5; BCAR1; DDR1; PAPPA2;	GO:0001558~regulation of cell growth	6	69	8.69565217391304	0.00221114775320674	0.0195198579709523	1	1	0.727968588662397	0.999609384753994	0.170783900824764
up	GSTA4; CYP2E1; NQO1; AADAC; ALDH3A1; CYP2J2; FMO2;	GO:0006805~xenobiotic metabolic process	7	94	7.4468085106383	0.00222773015595845	0.0196173252539625	1	1	0.728857439198004	0.999609384753994	0.171636665369467
down	GATA1; TAL1; SPI1; TRIM10;	GO:0030218~erythrocyte differentiation	4	46	8.69565217391304	0.00227172585579138	0.0257293648805654	1	1	0.75126949204239	0.97926915095487	0.206258969164337
down	CCR2; IRF8; IL18; IL23A;	GO:0032729~positive regulation of interferon-gamma production	4	46	8.69565217391304	0.00227172585579138	0.0257293648805654	1	1	0.75126949204239	0.97926915095487	0.206258969164337
down	TNNT2; KCNQ1; MYBPC3; RYR2;	GO:0060048~cardiac muscle contraction	4	46	8.69565217391304	0.00227172585579138	0.0257293648805654	1	1	0.75126949204239	0.97926915095487	0.206258969164337
down	NCKAP1L; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	3	21	14.2857142857143	0.00228402945147876	0.0257293648805654	1	1	0.752044510308442	0.97926915095487	0.206258969164337
down	NCR3; IL18RAP; RAET1E;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	3	21	14.2857142857143	0.00228402945147876	0.0257293648805654	1	1	0.752044510308442	0.97926915095487	0.206258969164337
up	MEIS2; B4GALT2; HRH1; LRRN4; NDRG4;	GO:0008542~visual learning	5	47	10.6382978723404	0.00228992699813046	0.0199663585551277	1	1	0.732547007459016	0.999609384753994	0.174690441107971
up	LRP5; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.00228992699813046	0.0199663585551277	1	1	0.732547007459016	0.999609384753994	0.174690441107971
up	FGF5; PTN; MDK; FGFR2; GAREM1;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00228992699813046	0.0199663585551277	1	1	0.732547007459016	0.999609384753994	0.174690441107971
up	ZNF423; ACOT11; FOXC2; LGR4; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	5	47	10.6382978723404	0.00228992699813046	0.0199663585551277	1	1	0.732547007459016	0.999609384753994	0.174690441107971
up	MMP2; COL4A2; HMGA2; LAMB3;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00240247435581442	0.0208449980872134	1	1	0.738518858063301	0.999609384753994	0.182377868287602
up	TERT; TK1; TYMS; LOX;	GO:0071897~DNA biosynthetic process	4	28	14.2857142857143	0.00240247435581442	0.0208449980872134	1	1	0.738518858063301	0.999609384753994	0.182377868287602
down	EREG; OSM; TAL1; MACC1;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.00244378077709095	0.02654610684292	1	1	0.765361345905999	0.97926915095487	0.212806365728943
up	MYO1C; TLR3; WNT5A; GBP6; RAB7B; CX3CL1; CCL26;	GO:0071346~cellular response to interferon-gamma	7	96	7.29166666666667	0.00248956285462898	0.021547805636642	1	1	0.743383224078062	0.999609384753994	0.18852689944342
down	NCR3; NCR1; IL18;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.00257432974636307	0.0271983534072272	1	1	0.776631787042463	0.97926915095487	0.218035088032018
down	IFNG; SPI1; CEBPE;	GO:0030225~macrophage differentiation	3	22	13.6363636363636	0.00257432974636307	0.0271983534072272	1	1	0.776631787042463	0.97926915095487	0.218035088032018
up	GABRP; SLC26A4; FXYD3; CLCA4; ANO4; ANO1; CLCA2;	GO:1902476~chloride transmembrane transport	7	97	7.21649484536082	0.00262903784697133	0.0220796096282614	1	1	0.751078702588187	0.999609384753994	0.193179779617963
up	APOE; APOD; HYAL2;	GO:0000302~response to reactive oxygen species	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	SNAI2; BMP4; MSX2;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	NQO1; NOS1; SPR;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	IGFBP5; SEMA6D; NDRG4;	GO:0014912~negative regulation of smooth muscle cell migration	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	SLC16A14; SLC16A9; SLC16A12;	GO:0015718~monocarboxylic acid transport	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	APOE; SERPINE2; TFPI;	GO:0030195~negative regulation of blood coagulation	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	NPR1; SNCAIP; COMT;	GO:0042417~dopamine metabolic process	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	DLX2; HES1; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	EDNRA; LHX1; FLRT3;	GO:0060322~head development	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	FLRT2; COL4A1; CAV2;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	WNT5A; SFRP1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	SNX33; EHD2; PACSIN3;	GO:0097320~plasma membrane tubulation	3	13	23.0769230769231	0.00263832623524141	0.0220796096282614	1	1	0.751706694814432	0.999609384753994	0.193179779617963
up	COL4A1; EDNRA; KDR; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	4	29	13.7931034482759	0.00269577572024438	0.0225071840793988	1	1	0.754817201668425	0.999609384753994	0.196920730641629
up	TNFRSF21; HYAL2; POSTN; SFRP1; HAS2; ADAMTS7; CX3CL1; CCL26;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.00270740191771035	0.0225510653851639	1	1	0.755365135041188	0.999609384753994	0.197304658669333
down	CXCR3; IL18; LMO7; SPINK5;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.00281434059098484	0.0295505762053409	1	1	0.796458387248711	0.97926915095487	0.23689163780835
down	EREG; S100A8; SERPINB2; NLRP6; GRHL3;	GO:0042060~wound healing	5	82	6.09756097560976	0.00284266105738862	0.0296648248994972	1	1	0.798787757126202	0.97926915095487	0.237807510314121
down	TRPM2; AZU1; RYR2;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.00288640235217386	0.0297561842487741	1	1	0.802419853904332	0.97926915095487	0.238539890817598
down	IL2RA; IL18; IL23A;	GO:0042104~positive regulation of activated T cell proliferation	3	23	13.0434782608696	0.00288640235217386	0.0297561842487741	1	1	0.802419853904332	0.97926915095487	0.238539890817598
up	SOX9; BCAR1; EFEMP1; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	5	50	10	0.00293432030408414	0.0231191128101143	1	1	0.767825161954702	0.999609384753994	0.202274641300911
up	PTN; HRH1; CX3CL1; PLK2; BAIAP2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.00293432030408414	0.0231191128101143	1	1	0.767825161954702	0.999609384753994	0.202274641300911
up	BMP7; WNT5A; PLK1; TNKS1BP1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	4	30	13.3333333333333	0.00301269012457472	0.0231191128101143	1	1	0.771814881543878	0.999609384753994	0.202274641300911
up	LGI3; PCLO; RAB13; RAB3B;	GO:0017157~regulation of exocytosis	4	30	13.3333333333333	0.00301269012457472	0.0231191128101143	1	1	0.771814881543878	0.999609384753994	0.202274641300911
up	GJA1; HRH1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.00301269012457472	0.0231191128101143	1	1	0.771814881543878	0.999609384753994	0.202274641300911
up	MATN2; KCNK2; APOD; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.00301269012457472	0.0231191128101143	1	1	0.771814881543878	0.999609384753994	0.202274641300911
up	MSX2; HMGA2; OSR1; SOX21;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.00301269012457472	0.0231191128101143	1	1	0.771814881543878	0.999609384753994	0.202274641300911
up	DOC2B; DHCR24; DUOXA2; WNK4; CCDC68; PARD3;	GO:0008104~protein localization	6	74	8.10810810810811	0.00306295590619876	0.0231191128101143	1	1	0.774927844268287	0.999609384753994	0.202274641300911
up	IL33; PLK1; SH3RF2; PLK2; RNF180; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	6	74	8.10810810810811	0.00306295590619876	0.0231191128101143	1	1	0.774927844268287	0.999609384753994	0.202274641300911
up	CXCL14; LOX; EPHA2; BCAR1; CX3CL1; ARHGEF16;	GO:0060326~cell chemotaxis	6	74	8.10810810810811	0.00306295590619876	0.0231191128101143	1	1	0.774927844268287	0.999609384753994	0.202274641300911
up	CLDN14; GLDC; SOX9; HES1; PARD3; WASF1; MAGI1; CARD10;	GO:0065003~protein-containing complex assembly	8	128	6.25	0.00310544627260789	0.0232682180674168	1	1	0.776871240451793	0.999609384753994	0.203579198819387
up	HOXA5; CCBE1; NDN;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	CYP7B1; ISL1; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	NPR1; HYAL2; HAS2;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	JAG1; TBX2; SIX1;	GO:0035909~aorta morphogenesis	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	IGFBP5; BVES; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	NOS1; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	DLL1; PITX2; SMO;	GO:0070986~left/right axis specification	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	NFIB; BMP4; SOX9;	GO:1902894~negative regulation of pri-miRNA transcription by RNA polymerase II	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	PTN; HMGA2; SMO;	GO:2000036~regulation of stem cell population maintenance	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	MYO1C; SNAI2; GJA1;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.00316158556226764	0.0232682180674168	1	1	0.780417714408038	0.999609384753994	0.203579198819387
up	EDNRA; GNA15; NTF4; NTRK2;	GO:0007202~activation of phospholipase C activity	4	31	12.9032258064516	0.00335411431314281	0.0245321584060445	1	1	0.79097876116172	0.999609384753994	0.214637714806636
up	FGFR2; GDNF; WNT7B; TEAD3;	GO:0048568~embryonic organ development	4	31	12.9032258064516	0.00335411431314281	0.0245321584060445	1	1	0.79097876116172	0.999609384753994	0.214637714806636
up	TYMS; GLI3; CCND1; PTPN3;	GO:0097421~liver regeneration	4	31	12.9032258064516	0.00335411431314281	0.0245321584060445	1	1	0.79097876116172	0.999609384753994	0.214637714806636
up	LDLR; APOD; PC; NR2F2; PLTP; ANGPTL4; EPHX3; LIPG;	GO:0006629~lipid metabolic process	8	130	6.15384615384615	0.00339509363285528	0.0247806834233149	1	1	0.793038406643393	0.999609384753994	0.21681211955718
up	PDLIM1; NQO1; DHCR24; SCARA3; CYGB; DUOX2; DUOX1;	GO:0006979~response to oxidative stress	7	102	6.86274509803922	0.0034185013521042	0.0249001950338454	1	1	0.794085585947278	0.999609384753994	0.21785775518991
down	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.00357789755855542	0.0349770330293263	1	1	0.855188764991567	0.97926915095487	0.280392726775199
down	CNR2; CCR2; NMU; PROK2;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.00366724327013102	0.0354430727414367	1	1	0.861176447232629	0.97926915095487	0.284128725353312
down	EREG; SCEL; CSTA; CERS3;	GO:0030216~keratinocyte differentiation	4	53	7.54716981132075	0.00366724327013102	0.0354430727414367	1	1	0.861176447232629	0.97926915095487	0.284128725353312
up	DLC1; VANGL2; FZD10; BAIAP2; ARHGAP40; RHOD;	GO:0032956~regulation of actin cytoskeleton organization	6	77	7.79220779220779	0.00367936548572578	0.026455298628809	1	1	0.807767432719636	0.999609384753994	0.231463728067874
up	PARD3; PARVA; PARD6G; CAP2; RHOD;	GO:0007163~establishment or maintenance of cell polarity	5	53	9.43396226415094	0.00370030954963618	0.026455298628809	1	1	0.808882046871927	0.999609384753994	0.231463728067874
up	CDH13; CCBE1; PARVA; KDR;	GO:0002040~sprouting angiogenesis	4	32	12.5	0.00372092950053426	0.026455298628809	1	1	0.810010009696701	0.999609384753994	0.231463728067874
up	LRP4; NR2F2; INTU; ZNRF3;	GO:0060173~limb development	4	32	12.5	0.00372092950053426	0.026455298628809	1	1	0.810010009696701	0.999609384753994	0.231463728067874
up	BMP4; JAG1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	MDK; CXCL17; TRPV4;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	DLL1; LAMB2; ROR1;	GO:0014002~astrocyte development	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	TBX2; FOXC2; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	KRT14; KRT16; PPP1R13L;	GO:0042633~hair cycle	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	SHISA9; UNC13B; GRIK2;	GO:0048172~regulation of short-term neuronal synaptic plasticity	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	SERPINB5; HES1; SIX1;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	OBSL1; FHOD3; MYOM3;	GO:0055003~cardiac myofibril assembly	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	KCNK2; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	WNT5A; LHX1; FOXL2;	GO:0060065~uterus development	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
up	GLI3; MYH14; SHANK2;	GO:0071625~vocalization behavior	3	15	20	0.00374409734831449	0.026455298628809	1	1	0.811151562435027	0.999609384753994	0.231463728067874
down	F13A1; GP9; GATA1; GP5; P2RX1; HBG2; F2RL3;	GO:0007596~blood coagulation	7	171	4.09356725146199	0.00382916745210615	0.0367989482261727	1	1	0.869037893939804	0.97926915095487	0.294998075649949
down	JCHAIN; VIL1; CD3G; NCKAP1L; OCLN; NFE4;	GO:0065003~protein-containing complex assembly	6	128	4.6875	0.0038726577611059	0.0370078137732648	1	1	0.871114292999468	0.97926915095487	0.29667244237595
up	NKX2-8; FGFR2; PARD3; BAIAP2; SLITRK6; ISL1;	GO:0007409~axonogenesis	6	78	7.69230769230769	0.00390393892891761	0.0275297685425664	1	1	0.815923236143779	0.999609384753994	0.240864522042062
down	XCL1; NCKAP1L; IL23A;	GO:0090023~positive regulation of neutrophil chemotaxis	3	26	11.5384615384615	0.0039582740888946	0.0376146604760319	1	1	0.874778573645706	0.97926915095487	0.301537217543722
up	LDLR; APOE; NTF4; LRRN4;	GO:0007616~long-term memory	4	33	12.1212121212121	0.00411400022486264	0.028724971984248	1	1	0.820444328631038	0.999609384753994	0.251321642496183
up	ERBB2; TYRO3; NYAP1; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	4	33	12.1212121212121	0.00411400022486264	0.028724971984248	1	1	0.820444328631038	0.999609384753994	0.251321642496183
up	CDKN2B; NKX3-2; PITX2; BARX1;	GO:0048536~spleen development	4	33	12.1212121212121	0.00411400022486264	0.028724971984248	1	1	0.820444328631038	0.999609384753994	0.251321642496183
up	EYA2; KITLG; BCL2L10; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	4	33	12.1212121212121	0.00411400022486264	0.028724971984248	1	1	0.820444328631038	0.999609384753994	0.251321642496183
up	TERT; MMP2; HPGD; IGFBP5;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	4	33	12.1212121212121	0.00411400022486264	0.028724971984248	1	1	0.820444328631038	0.999609384753994	0.251321642496183
up	FGFR2; WNT5B; WNT7B; SOX2; WNT5A;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.0042844328900955	0.0291174638136723	1	1	0.824138727069902	0.999609384753994	0.254755647280986
down	GJB6; AIF1; EEF1A2;	GO:0051602~response to electrical stimulus	3	27	11.1111111111111	0.0043623320134285	0.0394698231640526	1	1	0.894278062752843	0.97926915095487	0.316409094305527
up	EDN2; EDNRA; BDKRB2;	GO:0042310~vasoconstriction	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	C3; WNT5A; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	DOC2B; SYT8; SYT12;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	CDC20; CSMD3; MARK1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	DSCAM; VSTM2L; IGSF9;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.00438780280189355	0.0291174638136723	1	1	0.826388865383394	0.999609384753994	0.254755647280986
up	GJB3; COL5A2; DHCR24; DACT2;	GO:0043588~skin development	4	34	11.7647058823529	0.00453417328992378	0.0291306233145738	1	1	0.829753712056052	0.999609384753994	0.254870782898275
up	TBX3; SLIT3; HES1; ROBO1;	GO:0060412~ventricular septum morphogenesis	4	34	11.7647058823529	0.00453417328992378	0.0291306233145738	1	1	0.829753712056052	0.999609384753994	0.254870782898275
up	PLCB4; NCEH1; ASPG; PLCD3; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	6	81	7.40740740740741	0.00463862496514622	0.029747703580829	1	1	0.831868237004381	0.999609384753994	0.260269765572732
down	EREG; ELANE; AIF1; IL18;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.00468024830177116	0.0421222347159405	1	1	0.90478378112229	0.97926915095487	0.337672101574906
down	MS4A1; CXCR5; FCRL1;	GO:0042113~B cell activation	3	28	10.7142857142857	0.00479048842864283	0.0424407334225075	1	1	0.908144058980079	0.97926915095487	0.340225340459801
down	HBA1; HBG2; HBM;	GO:0042744~hydrogen peroxide catabolic process	3	28	10.7142857142857	0.00479048842864283	0.0424407334225075	1	1	0.908144058980079	0.97926915095487	0.340225340459801
down	NCKAP1L; GPR174; SIT1;	GO:0043029~T cell homeostasis	3	28	10.7142857142857	0.00479048842864283	0.0424407334225075	1	1	0.908144058980079	0.97926915095487	0.340225340459801
up	MATN2; NTN1; NR2F2; NTRK2; APBB2; NDN; MARK1;	GO:0001764~neuron migration	7	109	6.42201834862385	0.0048120336428471	0.0308039766648802	1	1	0.835881636393437	0.999609384753994	0.269511351136465
up	GPR143; NCS1; PLCB4; PIK3C2G; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	5	57	8.7719298245614	0.00493143338193391	0.0315113252202997	1	1	0.838343674928765	0.999609384753994	0.275700112638576
up	KLK8; EMP2; PMP22; SNCAIP;	GO:0008219~cell death	4	35	11.4285714285714	0.0049822767903589	0.0316647393857639	1	1	0.839476404553703	0.999609384753994	0.277042369823989
up	TBX3; FOSL1; FGFR2; CCND1;	GO:0045787~positive regulation of cell cycle	4	35	11.4285714285714	0.0049822767903589	0.0316647393857639	1	1	0.839476404553703	0.999609384753994	0.277042369823989
up	DLL1; EDN2; IRX3; TRPV4;	GO:0097009~energy homeostasis	4	35	11.4285714285714	0.0049822767903589	0.0316647393857639	1	1	0.839476404553703	0.999609384753994	0.277042369823989
up	MSX2; ECM1; SULF1;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	FOXE1; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	P2RY1; PCSK9; MUC4;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	C1R; PRSS3; PRSS12;	GO:0031638~zymogen activation	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	APOE; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	LAMA1; WNT5A; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.00509448099551624	0.0320327934709191	1	1	0.841753091055205	0.999609384753994	0.280262562945826
up	ANXA8; RAB13; SNX33; MVB12A; TINAGL1; ANXA8L1;	GO:0016197~endosomal transport	6	83	7.2289156626506	0.00518184164841407	0.0325243252400457	1	1	0.844126657833366	0.999609384753994	0.284563091824451
down	XCL1; IL23A; CD1C;	GO:0001916~positive regulation of T cell mediated cytotoxicity	3	29	10.3448275862069	0.0052431375442612	0.0439338766639818	1	1	0.9191493019768	0.97926915095487	0.352195095144022
down	CD19; XCL1; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	3	29	10.3448275862069	0.0052431375442612	0.0439338766639818	1	1	0.9191493019768	0.97926915095487	0.352195095144022
up	HOXA5; PPP1R13L; SMO; WWTR1; SLITRK6; ETNK2;	GO:0035264~multicellular organism growth	6	84	7.14285714285714	0.00547026486118596	0.0342738718736253	1	1	0.850078287963681	0.999609384753994	0.299870293301131
up	GJA1; WNT5A; DUOXA2; AJUBA; FRMD6;	GO:0034613~cellular protein localization	5	59	8.47457627118644	0.00564478829697068	0.0353048596665657	1	1	0.853766990593898	0.999609384753994	0.308890651812095
up	C1R; C3; CFI; CFH; C1S; CD59; SUSD4;	GO:0030449~regulation of complement activation	7	113	6.19469026548673	0.00577944653321705	0.0359252142632101	1	1	0.856686003305212	0.999609384753994	0.314318282385389
up	SOX9; ISL1; TBX2;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	CRYAB; HYAL2; TP63;	GO:0010259~multicellular organism aging	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	POU3F1; NTRK2; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	SOX2; MAGI1; MYO10;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	FOSL1; ADORA2B; CDKN2B;	GO:0031668~cellular response to extracellular stimulus	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	SNAI2; NOS1; ISL1;	GO:0035066~positive regulation of histone acetylation	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	DLL1; MEIS2; HMGB3;	GO:0045638~negative regulation of myeloid cell differentiation	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	EDN2; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	GLI3; SHROOM2; TENM3;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	BMP7; GJC1; TBX2;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.0058657553232021	0.0359252142632101	1	1	0.858414841463168	0.999609384753994	0.314318282385389
up	GJB3; DCN; ETNK2; PHLDA2;	GO:0001890~placenta development	4	37	10.8108108108108	0.00596548864985325	0.0364100514146215	1	1	0.859565057185599	0.999609384753994	0.318560238454231
up	FXYD3; ANO4; ANO1; WNK4;	GO:0006821~chloride transport	4	37	10.8108108108108	0.00596548864985325	0.0364100514146215	1	1	0.859565057185599	0.999609384753994	0.318560238454231
up	HRH1; P2RY1; ANO1; ADRA1D; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.00602742157772895	0.0364357952271102	1	1	0.860750664161027	0.999609384753994	0.318785477220079
up	JUP; FGFR2; CDH3; KANK1; SFRP1; LGR4; ZBED2; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	8	144	5.55555555555556	0.0060507819874932	0.0364357952271102	1	1	0.860750664161027	0.999609384753994	0.318785477220079
down	WNT1; CCR2; HHEX; F2RL3;	GO:0009611~response to wounding	4	62	6.45161290322581	0.00619090772665176	0.0505584959211739	1	1	0.941496483737335	0.97926915095487	0.40530123069915
down	ASS1; S100A8; HAAO;	GO:0010043~response to zinc ion	3	31	9.67741935483871	0.0062233796992569	0.0505584959211739	1	1	0.942650278447797	0.97926915095487	0.40530123069915
down	GATA1; TAL1; NCKAP1L;	GO:0045648~positive regulation of erythrocyte differentiation	3	31	9.67741935483871	0.0062233796992569	0.0505584959211739	1	1	0.942650278447797	0.97926915095487	0.40530123069915
down	GJB6; KCNQ1; TMPRSS3; GRAP; LOXHD1; MYO7B;	GO:0007605~sensory perception of sound	6	143	4.1958041958042	0.00645422243853688	0.051786001735619	1	1	0.948700665344125	0.97926915095487	0.415141507950685
up	INHA; KITLG; FOXL2; MMP19;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.00650215199633075	0.03779576037276	1	1	0.866570916585857	0.999609384753994	0.330684137184994
up	JUP; KCNJ5; DSG2; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.00650215199633075	0.03779576037276	1	1	0.866570916585857	0.999609384753994	0.330684137184994
up	POSTN; SEMA6D; HAS2;	GO:0014911~positive regulation of smooth muscle cell migration	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	MYO1D; MYO1B; MYO1C;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	TBX3; DHCR24; LGR4;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	APOE; NOS1; BDKRB2;	GO:0042311~vasodilation	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	APOE; CYP51A1; RHBDF1;	GO:0050709~negative regulation of protein secretion	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	NOS1; ADRA1B; RNF207;	GO:0055117~regulation of cardiac muscle contraction	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	TERT; HMGA2; PLK2;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.00670309975673877	0.0385210602903494	1	1	0.869445115314169	0.999609384753994	0.337029959443442
up	FZD6; WNT5A; ROR1; PRICKLE2; VANGL1; GPC6;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	6	88	6.81818181818182	0.00674216509184755	0.0386827624394495	1	1	0.869739296848334	0.999609384753994	0.338444730177745
up	ADRA1D; GNA15; GNAI1; GNA11; ADRA1B;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	5	62	8.06451612903226	0.00684671223267008	0.0390925182316969	1	1	0.870957193775585	0.999609384753994	0.342029781497775
up	DLL1; IGFBP2; HMGA2; KCTD11; NDN;	GO:0040008~regulation of growth	5	62	8.06451612903226	0.00684671223267008	0.0390925182316969	1	1	0.870957193775585	0.999609384753994	0.342029781497775
up	TPBG; NTRK2; SLITRK6; FLRT3; FLRT2;	GO:0051965~positive regulation of synapse assembly	5	62	8.06451612903226	0.00684671223267008	0.0390925182316969	1	1	0.870957193775585	0.999609384753994	0.342029781497775
down	MMP8; IL18; IL23A; TLR7;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	4	64	6.25	0.00687599890616397	0.0549111461942954	1	1	0.958047469928796	0.97926915095487	0.440194169667302
up	ANXA8; LAPTM4B; SNX33; ANXA8L1;	GO:0007032~endosome organization	4	39	10.2564102564103	0.00706985433738261	0.0403015851116496	1	1	0.874144818640191	0.999609384753994	0.352608196485406
up	HOXC11; BMP4; PAX9;	GO:0007492~endoderm development	3	20	15	0.00760784490653021	0.0431598893735849	1	1	0.881262815910672	0.999609384753994	0.37761618334288
up	FGF5; MSX2; P2RY1;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.00760784490653021	0.0431598893735849	1	1	0.881262815910672	0.999609384753994	0.37761618334288
up	NRP2; WNT5A; SEMA3F;	GO:0099175~regulation of postsynapse organization	3	20	15	0.00760784490653021	0.0431598893735849	1	1	0.881262815910672	0.999609384753994	0.37761618334288
down	CD3D; TBX21; CD3G;	GO:0030217~T cell differentiation	3	34	8.82352941176471	0.00788603997529935	0.0615328165045147	1	1	0.967437715067712	0.97926915095487	0.493276665044542
up	CRYAB; WNT5A; SIX5; SLITRK6;	GO:0002088~lens development in camera-type eye	4	41	9.75609756097561	0.00830124358305206	0.0445248519454611	1	1	0.889579633774076	0.999609384753994	0.389558566983771
up	NGFR; GJA1; VCAM1; LGMN;	GO:1904646~cellular response to amyloid-beta	4	41	9.75609756097561	0.00830124358305206	0.0445248519454611	1	1	0.889579633774076	0.999609384753994	0.389558566983771
up	GHR; ADORA2B; WNT5A; CSPG4; CXCL17; LPAR3; MUC20;	GO:0000187~activation of MAPK activity	7	122	5.73770491803279	0.00847932143375929	0.0454111919447926	1	1	0.891882408612599	0.999609384753994	0.397313367391034
down	IFNG; VIL1; CCR6;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.00849271266391538	0.0656807460266006	1	1	0.9721422218502	0.97926915095487	0.526528463966248
down	ANXA9; CSTA; ICAM3; DSG1; PKP1; ICOS;	GO:0098609~cell-cell adhesion	6	152	3.94736842105263	0.00850196871890985	0.0656807460266006	1	1	0.9721422218502	0.97926915095487	0.526528463966248
up	KDR; EFNB2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
up	FMO2; CYP2J2; CYP2E1;	GO:0006082~organic acid metabolic process	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
up	CLDN7; CLDN14; CLDN12;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
up	CXADR; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
up	LRP4; NGFR; EFNB3;	GO:0050771~negative regulation of axonogenesis	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
up	KLK8; WNT5A; IGSF9;	GO:0050807~regulation of synapse organization	3	21	14.2857142857143	0.00858118389201856	0.045543314809214	1	1	0.893071341273793	0.999609384753994	0.398469341896976
down	LILRA5; OSM; MMP8; FLT3; FCRL3;	GO:0043410~positive regulation of MAPK cascade	5	109	4.58715596330275	0.00887227078641861	0.0661918096828862	1	1	0.975457284840312	0.97926915095487	0.530625396145186
up	GJA1; ISL1; DOC2B; TM7SF3;	GO:0032024~positive regulation of insulin secretion	4	42	9.52380952380952	0.00896630634579865	0.0473036132103237	1	1	0.898097283887022	0.999609384753994	0.413870613156454
up	BMP7; DLX2; JAG1; DLL1;	GO:0045746~negative regulation of Notch signaling pathway	4	42	9.52380952380952	0.00896630634579865	0.0473036132103237	1	1	0.898097283887022	0.999609384753994	0.413870613156454
up	INHA; BMP4; HPGD; BMP7;	GO:0045786~negative regulation of cell cycle	4	42	9.52380952380952	0.00896630634579865	0.0473036132103237	1	1	0.898097283887022	0.999609384753994	0.413870613156454
up	ADH7; LYPD6; PCSK9; DKK3;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.00896630634579865	0.0473036132103237	1	1	0.898097283887022	0.999609384753994	0.413870613156454
down	IL18RAP; LTF; S100A8; CD40LG; S100A12; IL18;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	6	154	3.8961038961039	0.00901367598265135	0.0669531128667683	1	1	0.976159684325345	0.97926915095487	0.5367283687859
up	APOE; STC1; GRIK2; TRPV4; SLC24A3; ATP13A5;	GO:0006874~cellular calcium ion homeostasis	6	94	6.38297872340426	0.00903316611270211	0.0475854286294129	1	1	0.899425981359485	0.999609384753994	0.416336283585831
up	FOXE1; HOXA5; SIX1;	GO:0030878~thyroid gland development	3	22	13.6363636363636	0.00962417802687643	0.0503988020934062	1	1	0.906555577553188	0.999609384753994	0.440951160157815
up	MET; KANK1; DLC1;	GO:0035024~negative regulation of Rho protein signal transduction	3	22	13.6363636363636	0.00962417802687643	0.0503988020934062	1	1	0.906555577553188	0.999609384753994	0.440951160157815
up	CAV2; BVES; NDRG4;	GO:0048278~vesicle docking	3	22	13.6363636363636	0.00962417802687643	0.0503988020934062	1	1	0.906555577553188	0.999609384753994	0.440951160157815
up	MET; BMP4; BMP7;	GO:0048754~branching morphogenesis of an epithelial tube	3	22	13.6363636363636	0.00962417802687643	0.0503988020934062	1	1	0.906555577553188	0.999609384753994	0.440951160157815
up	MYO1C; RHOD; LTBP2; AP1M2;	GO:0006605~protein targeting	4	43	9.30232558139535	0.00966515891692465	0.0505386448536385	1	1	0.908087120439243	0.999609384753994	0.442174677876547
down	CLIC3; SLC26A9; NMUR1;	GO:0006821~chloride transport	3	37	8.10810810810811	0.00978626273456018	0.0720624801363068	1	1	0.97926915095487	0.97926915095487	0.577687515309297
down	HP; ASS1; ORM1;	GO:0006953~acute-phase response	3	37	8.10810810810811	0.00978626273456018	0.0720624801363068	1	1	0.97926915095487	0.97926915095487	0.577687515309297
up	PTN; FBLN1; BCAR1; DOCK1; FERMT2; ITGB6;	GO:0007229~integrin-mediated signaling pathway	6	96	6.25	0.00990717913019679	0.0517277494408505	1	1	0.910572965459683	0.999609384753994	0.452578437995851
up	MDK; NTRK2; SMO; GNG12; BTBD3;	GO:0021987~cerebral cortex development	5	69	7.2463768115942	0.010324336767645	0.0518622513976034	1	1	0.913913382588407	0.999609384753994	0.453755227748983
down	ATP10A; S100B; VIL1; EPB42; PALMD; RND3;	GO:0008360~regulation of cell shape	6	159	3.77358490566038	0.0103886591836853	0.074231523432775	1	1	0.97926915095487	0.97926915095487	0.595075610059365
up	LRP5; IGFBP5; SFRP1; TWIST2;	GO:0045668~negative regulation of osteoblast differentiation	4	44	9.09090909090909	0.0103984293620497	0.0518622513976034	1	1	0.915061783860375	0.999609384753994	0.453755227748983
up	HOXA5; SIX1; HOXA4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	4	44	9.09090909090909	0.0103984293620497	0.0518622513976034	1	1	0.915061783860375	0.999609384753994	0.453755227748983
down	TNNC2; TNNT2; MYBPC3;	GO:0030049~muscle filament sliding	3	38	7.89473684210526	0.0104735835531252	0.074231523432775	1	1	0.97926915095487	0.97926915095487	0.595075610059365
down	TYROBP; IFNG; FCGR2B;	GO:1901216~positive regulation of neuron death	3	38	7.89473684210526	0.0104735835531252	0.074231523432775	1	1	0.97926915095487	0.97926915095487	0.595075610059365
up	VCAM1; KDR; GPR143;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	DLL1; APOE; WNT5A;	GO:0045807~positive regulation of endocytosis	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	TYMS; GLI3; KDF1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	RHOD; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	ANXA1; STC1; ISL1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	TBX3; CDKN2B; TBX2;	GO:0090398~cellular senescence	3	23	13.0434782608696	0.0107377623245254	0.0527939980955832	1	1	0.917514091960928	0.999609384753994	0.461907302210713
up	TERT; CSF3; BMP4; WNT5A; PLK2;	GO:0032092~positive regulation of protein binding	5	70	7.14285714285714	0.010903850268746	0.0535362412640232	1	1	0.918777498758304	0.999609384753994	0.468401365018719
down	TRPM2; CCR5; RYR2; NMUR1;	GO:0006816~calcium ion transport	4	74	5.40540540540541	0.0110519741182435	0.0780058422204659	1	1	0.97926915095487	0.97926915095487	0.625332365562674
up	EPHA2; SFN; BCL2L10; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	4	45	8.88888888888889	0.0111667211821356	0.0547509598126869	1	1	0.921406750742032	0.999609384753994	0.479029227806127
up	PLK1; CDC20; TRIP13;	GO:0007094~mitotic spindle assembly checkpoint	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	ZDHHC1; ZDHHC16; ZDHHC9;	GO:0018345~protein palmitoylation	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	SOX9; FOXA2; ANXA1;	GO:0031018~endocrine pancreas development	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	LDLR; NCEH1; PCSK9;	GO:0034383~low-density lipoprotein particle clearance	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	TLR3; FBN1; SFRP1;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	CAV2; SMO; SIX1;	GO:0048741~skeletal muscle fiber development	3	24	12.5	0.0119227508286108	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	MSX2; WNT5A; JAG1; WWTR1;	GO:0045599~negative regulation of fat cell differentiation	4	46	8.69565217391304	0.0119706130501999	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	EPHA2; XDH; HYAL2; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	4	46	8.69565217391304	0.0119706130501999	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	GJA1; FGFR2; STC1; SULF1;	GO:0060348~bone development	4	46	8.69565217391304	0.0119706130501999	0.0578906696689993	1	1	0.928646719972588	0.999609384753994	0.506499299438664
up	VCAM1; CXADR; CADM1; TENM3;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	4	47	8.51063829787234	0.0128106585945591	0.0597977166722613	1	1	0.935240661179494	0.999609384753994	0.523184509277687
up	WNT5A; NBL1; SOSTDC1; SFRP1;	GO:0030514~negative regulation of BMP signaling pathway	4	47	8.51063829787234	0.0128106585945591	0.0597977166722613	1	1	0.935240661179494	0.999609384753994	0.523184509277687
down	CD8B; TRAT1; SLA; LTK; FLT3;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	5	120	4.16666666666667	0.0128544538389018	0.0876629469487812	1	1	0.97926915095487	0.97926915095487	0.702748363805169
up	FZD6; GNA11; GNA15; P2RY1; TYRO3; PDPN;	GO:0030168~platelet activation	6	102	5.88235294117647	0.0128879596803497	0.0597977166722613	1	1	0.937017934395417	0.999609384753994	0.523184509277687
down	S100B; NEFH; PTPRZ1; ISL2;	GO:0007409~axonogenesis	4	78	5.12820512820513	0.0130952459423987	0.0876629469487812	1	1	0.97926915095487	0.97926915095487	0.702748363805169
up	CYP2E1; AOX1; FMO2;	GO:0017144~drug metabolic process	3	25	12	0.0131798417733862	0.0606718333911404	1	1	0.938851628983275	0.999609384753994	0.53083236528404
up	SERPINB7; BMP4; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	3	25	12	0.0131798417733862	0.0606718333911404	1	1	0.938851628983275	0.999609384753994	0.53083236528404
up	NOS1; CYP2J2; CYP2E1;	GO:0042738~exogenous drug catabolic process	3	25	12	0.0131798417733862	0.0606718333911404	1	1	0.938851628983275	0.999609384753994	0.53083236528404
up	WNT5A; SEMA3F; SEMA6D;	GO:0048843~negative regulation of axon extension involved in axon guidance	3	25	12	0.0131798417733862	0.0606718333911404	1	1	0.938851628983275	0.999609384753994	0.53083236528404
down	CGNL1; PACSIN1; MYO5B; RND3; MYO7B;	GO:0007015~actin filament organization	5	121	4.13223140495868	0.0132674535866988	0.0878129904707184	1	1	0.97926915095487	0.97926915095487	0.703951184873945
up	CCNO; PLK1; GEM; CDH13; FBXL7; TUBB6; PLK2;	GO:0000278~mitotic cell cycle	7	134	5.22388059701492	0.0133895535885882	0.0614773277608329	1	1	0.940744475009451	0.999609384753994	0.537879827962978
up	EPN2; LDLR; SFN; WNT5A; DHCR24; TRIP10; BAIAP2L2;	GO:0061024~membrane organization	7	134	5.22388059701492	0.0133895535885882	0.0614773277608329	1	1	0.940744475009451	0.999609384753994	0.537879827962978
down	TRIM16; SPI1; IRF4;	GO:0043966~histone H3 acetylation	3	42	7.14285714285714	0.0134975260711027	0.088989503282735	1	1	0.97926915095487	0.97926915095487	0.713382677681545
up	NTF4; GDNF; SLITRK6; FOXA2;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.0136873862276413	0.0626822085974777	1	1	0.944429649707251	0.999609384753994	0.548421618257632
up	CKB; PTN; LHX1; CNTN1;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.0136873862276413	0.0626822085974777	1	1	0.944429649707251	0.999609384753994	0.548421618257632
down	CLDN5; DSG1; PKP1;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.0143229422576583	0.0938647516723684	1	1	0.97926915095487	0.97926915095487	0.752465014611884
up	TMEM237; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	3	26	11.5384615384615	0.0145096225780692	0.0662762115178903	1	1	0.95120493989095	0.999609384753994	0.579866408441918
up	CACNB3; BAIAP2; SHANK2;	GO:2000463~positive regulation of excitatory postsynaptic potential	3	26	11.5384615384615	0.0145096225780692	0.0662762115178903	1	1	0.95120493989095	0.999609384753994	0.579866408441918
up	MYO1C; PARD3; ZDHHC1; ZDHHC9;	GO:0006612~protein targeting to membrane	4	49	8.16326530612245	0.0146012990175246	0.0665232928211546	1	1	0.95120493989095	0.999609384753994	0.582028181793709
up	DLL1; FUT1; LAMA1; SOX9;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.0146012990175246	0.0665232928211546	1	1	0.95120493989095	0.999609384753994	0.582028181793709
down	MMP8; FCGR2B; SLAMF1; SEMA3A;	GO:0046330~positive regulation of JNK cascade	4	81	4.93827160493827	0.0147755310838606	0.0938647516723684	1	1	0.97926915095487	0.97926915095487	0.752465014611884
down	ASS1; TCL1A; OCLN; XCL2; XCL1;	GO:0071356~cellular response to tumor necrosis factor	5	125	4	0.0150087816044828	0.0945553241082418	1	1	0.97926915095487	0.97926915095487	0.758000975542817
up	MYO1D; SH3RF2; CSRNP3; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	4	50	8	0.0155528746009808	0.0685575771025117	1	1	0.960994356081938	0.999609384753994	0.599826620976703
up	AMOTL1; TEAD3; WWTR1;	GO:0035329~hippo signaling	3	27	11.1111111111111	0.0159125746813799	0.0696298076292765	1	1	0.963677032634276	0.999609384753994	0.609207822019087
up	MECOM; SH3RF2; MARVELD3;	GO:0046329~negative regulation of JNK cascade	3	27	11.1111111111111	0.0159125746813799	0.0696298076292765	1	1	0.963677032634276	0.999609384753994	0.609207822019087
up	NGFR; PLK1; CARD10;	GO:1900182~positive regulation of protein localization to nucleus	3	27	11.1111111111111	0.0159125746813799	0.0696298076292765	1	1	0.963677032634276	0.999609384753994	0.609207822019087
down	S100A8; TLR8; TLR7;	GO:0002224~toll-like receptor signaling pathway	3	45	6.66666666666667	0.0160579416666036	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	PLK1; ESPL1; SNX33; RTKN;	GO:0000281~mitotic cytokinesis	4	51	7.84313725490196	0.016542565133989	0.0721190647467008	1	1	0.969364306925232	0.999609384753994	0.630986927241172
up	SLC26A4; SIX1; DZIP1L; B9D1;	GO:0032880~regulation of protein localization	4	51	7.84313725490196	0.016542565133989	0.0721190647467008	1	1	0.969364306925232	0.999609384753994	0.630986927241172
up	COL4A1; COL5A2; MMP2; NTRK2;	GO:0071230~cellular response to amino acid stimulus	4	51	7.84313725490196	0.016542565133989	0.0721190647467008	1	1	0.969364306925232	0.999609384753994	0.630986927241172
down	EREG; TAL1; CXCR3; IL18; PIK3R6; EPGN; PROK2;	GO:0001525~angiogenesis	7	230	3.04347826086957	0.0169240456585004	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	FLRT2; RBFOX2; FGF5; FGFR2; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.0171419639231688	0.0746402857171188	1	1	0.975525520740435	0.999609384753994	0.653045691849497
up	SHANK2; ADRA1D; ADRA1B;	GO:0007610~behavior	3	28	10.7142857142857	0.0173890782191313	0.0753455775957463	1	1	0.975525520740435	0.999609384753994	0.659216458995
up	TLR3; HSPA1B; AFAP1L2;	GO:0032757~positive regulation of interleukin-8 production	3	28	10.7142857142857	0.0173890782191313	0.0753455775957463	1	1	0.975525520740435	0.999609384753994	0.659216458995
up	GPX3; DUOX2; DUOX1;	GO:0042744~hydrogen peroxide catabolic process	3	28	10.7142857142857	0.0173890782191313	0.0753455775957463	1	1	0.975525520740435	0.999609384753994	0.659216458995
up	COBL; FGFR2; LGR4;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.0173890782191313	0.0753455775957463	1	1	0.975525520740435	0.999609384753994	0.659216458995
up	PINLYP; ANXA2P2; SCG5; NQO1;	GO:0043086~negative regulation of catalytic activity	4	52	7.69230769230769	0.0175707972797892	0.0759470358613597	1	1	0.9788027621315	0.999609384753994	0.664478761053633
up	TFAP2A; NQO1; GRIK2; PCSK9;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0175707972797892	0.0759470358613597	1	1	0.9788027621315	0.999609384753994	0.664478761053633
down	CEACAM8; CEACAM6; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0179057489957291	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	SCNN1A; SCNN1B; SHROOM2; SLC4A11; SLC24A3;	GO:0035725~sodium ion transmembrane transport	5	80	6.25	0.0179546804947247	0.0770095068450284	1	1	0.982222492278698	0.999609384753994	0.673774573521842
up	LRP5; CSF3; JUP; FOSL1; FOXA1; NHLH2;	GO:0051091~positive regulation of DNA-binding transcription factor activity	6	111	5.40540540540541	0.0184571381009777	0.0770095068450284	1	1	0.985794210432439	0.999609384753994	0.673774573521842
down	OSM; FLT3; IL18; PIK3R5;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.0185294831388529	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
down	GYPA; GPR15; SLAMF1; NECTIN4;	GO:0046718~viral entry into host cell	4	87	4.59770114942529	0.0185294831388529	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	GJA1; GJB2; CX3CL1; BVES;	GO:0002931~response to ischemia	4	53	7.54716981132075	0.0186379722304839	0.0772581050303431	1	1	0.987812528215647	0.999609384753994	0.675949618437087
up	FOSL1; ADORA2B; LGALS3BP; IL1RL2;	GO:0006968~cellular defense response	4	53	7.54716981132075	0.0186379722304839	0.0772581050303431	1	1	0.987812528215647	0.999609384753994	0.675949618437087
up	DLL1; CRIP2; JAG1; MECOM;	GO:0030097~hemopoiesis	4	53	7.54716981132075	0.0186379722304839	0.0772581050303431	1	1	0.987812528215647	0.999609384753994	0.675949618437087
up	TLR3; SH3RF2; TRPV4; WNT7B; TNFRSF19;	GO:0046330~positive regulation of JNK cascade	5	81	6.17283950617284	0.0187924196151751	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
down	FCGR2B; SSTR3; AIF1;	GO:0021549~cerebellum development	3	48	6.25	0.0188721220094581	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	NCS1; SFRP1; MARK1;	GO:0010975~regulation of neuron projection development	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	SCIN; SYT12; SYT8;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	PLXNA2; EPHA2; INTU;	GO:0021915~neural tube development	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	RAB13; EPB41L1; EHD2;	GO:0030866~cortical actin cytoskeleton organization	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	NFASC; VCAM1; PARVA;	GO:0034113~heterotypic cell-cell adhesion	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	NR2F2; CDKN2B; PLK1;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	MELTF; STEAP2; STEAP1;	GO:0055072~iron ion homeostasis	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	ERBB2; FGFR2; EPHA2;	GO:0070372~regulation of ERK1 and ERK2 cascade	3	29	10.3448275862069	0.0189394165498546	0.0776889160909449	1	1	0.98952827941135	0.999609384753994	0.679718887330206
up	RASAL1; WNT5A; LGMN; SYT12; SYT8;	GO:0071277~cellular response to calcium ion	5	82	6.09756097560976	0.0196554558741375	0.0805327705954246	1	1	0.99752985579473	0.999609384753994	0.704600449807549
up	PRSS3; UCN2; CYP39A1;	GO:0007586~digestion	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
up	UNC13B; GJA1; NTRK2;	GO:0014047~glutamate secretion	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
up	HMGA2; ZNF462; SMO;	GO:0043392~negative regulation of DNA binding	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
up	BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
up	PTN; MDK; TRIP13;	GO:0048477~oogenesis	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
up	TERT; KDR; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.0205637806328243	0.0835772484962088	1	1	0.999609384753994	0.999609384753994	0.731237314309559
down	FUT3; FUT7; ST6GALNAC5; B3GNT3;	GO:0006486~protein glycosylation	4	90	4.44444444444444	0.020608456066228	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	NGFR; IGFBP5; FOXA1; ADGRF5; TRPV4; ADRA1B;	GO:0042593~glucose homeostasis	6	114	5.26315789473684	0.0206297620080664	0.0837492631978844	1	1	0.999609384753994	0.999609384753994	0.732742312030089
down	EREG; VIL1; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	3	50	6	0.0208900211966352	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
down	TRPM2; XCL1; RYR2;	GO:0051209~release of sequestered calcium ion into cytosol	3	50	6	0.0208900211966352	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	SFN; CDKN2B; CCND1; CCNO;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	4	55	7.27272727272727	0.0208906283214446	0.0846142153980709	1	1	0.999609384753994	0.999609384753994	0.74030998547293
up	HSPA2; OCA2; TRIP13; SIX5; NECTIN2;	GO:0007286~spermatid development	5	84	5.95238095238095	0.0214584721163367	0.0858162929046055	1	1	0.999609384753994	0.999609384753994	0.750827248762714
down	GJB6; S100A8; ELANE; CNR2; FASLG;	GO:0032496~response to lipopolysaccharide	5	138	3.6231884057971	0.0217035649203944	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
down	IFNG; LTF; TCL1A;	GO:0071902~positive regulation of protein serine/threonine kinase activity	3	51	5.88235294117647	0.0219415944383563	0.0951582802131972	1	1	0.97926915095487	0.97926915095487	0.762834561806479
up	ARL4D; LTBP2; RAB3B; RAB13;	GO:0009306~protein secretion	4	56	7.14285714285714	0.0220767851380169	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	GJA1; PLK1; MISP;	GO:0000132~establishment of mitotic spindle orientation	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	ACOT7; ACOT11; ACSM4;	GO:0006637~acyl-CoA metabolic process	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	CDKN2B; TICRR; PLK2;	GO:0007093~mitotic cell cycle checkpoint	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	KDR; DDR1; FRK;	GO:0038083~peptidyl-tyrosine autophosphorylation	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	S100A2; PRSS3; CDH13;	GO:0043542~endothelial cell migration	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	MEIS2; FOXA1; LGMN;	GO:0045931~positive regulation of mitotic cell cycle	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	PLXNB1; SYDE1; CAPN6;	GO:0051493~regulation of cytoskeleton organization	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	MMP2; PAX9; CRISPLD1;	GO:0060325~face morphogenesis	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	MYO1C; ERBB2; CACNB3;	GO:0090314~positive regulation of protein targeting to membrane	3	31	9.67741935483871	0.0222622732626399	0.0873707842014912	1	1	0.999609384753994	0.999609384753994	0.764427864498513
up	FAM83G; BMP4; BMP7; FSTL1; SOSTDC1;	GO:0030509~BMP signaling pathway	5	85	5.88235294117647	0.0223989548963235	0.0878098564041917	1	1	0.999609384753994	0.999609384753994	0.768269412097502
down	CERS3; SGPP2; ELOVL4;	GO:0030148~sphingolipid biosynthetic process	3	52	5.76923076923077	0.0230215941832519	0.0981446909917581	1	1	0.97926915095487	0.97926915095487	0.786775067588357
up	BMP4; FGFR2; CDH13; CX3CL1;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.0233032363687345	0.091152990878807	1	1	0.999609384753994	0.999609384753994	0.797519294315199
up	SDC1; CCND1; SLC6A1; AQP3;	GO:0051592~response to calcium ion	4	57	7.01754385964912	0.0233032363687345	0.091152990878807	1	1	0.999609384753994	0.999609384753994	0.797519294315199
up	PLK1; CAPN6; NCKAP5;	GO:0001578~microtubule bundle formation	3	32	9.375	0.0240349131641175	0.0937043971376389	1	1	0.999609384753994	0.999609384753994	0.819842157223344
up	KCNK2; HES1; SLITRK6;	GO:0090102~cochlea development	3	32	9.375	0.0240349131641175	0.0937043971376389	1	1	0.999609384753994	0.999609384753994	0.819842157223344
up	TERT; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	3	32	9.375	0.0240349131641175	0.0937043971376389	1	1	0.999609384753994	0.999609384753994	0.819842157223344
down	CD3G; RND3; PARVG;	GO:0007163~establishment or maintenance of cell polarity	3	53	5.66037735849057	0.0241300135468453	0.101849014995493	1	1	0.97926915095487	0.97926915095487	0.816470711223863
down	TAL1; FLT3; CCR2;	GO:0030097~hemopoiesis	3	53	5.66037735849057	0.0241300135468453	0.101849014995493	1	1	0.97926915095487	0.97926915095487	0.816470711223863
down	CTLA4; CD40LG; ICOS;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.0241300135468453	0.101849014995493	1	1	0.97926915095487	0.97926915095487	0.816470711223863
down	KEL; MAL2; CMTM8;	GO:0042552~myelination	3	53	5.66037735849057	0.0241300135468453	0.101849014995493	1	1	0.97926915095487	0.97926915095487	0.816470711223863
down	IFNG; TAL1; TCL1A;	GO:0031334~positive regulation of protein-containing complex assembly	3	54	5.55555555555556	0.0252668341178683	0.106120703295047	1	1	0.97926915095487	0.97926915095487	0.850714620055161
down	ATP2C2; SKAP1; TESC; PACSIN1; EFR3B;	GO:0072659~protein localization to plasma membrane	5	144	3.47222222222222	0.0253560625319269	0.106233158538935	1	1	0.97926915095487	0.97926915095487	0.851616115400622
up	CSF3; NOS1; WNT5A; NTRK2; TNKS1BP1;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	5	88	5.68181818181818	0.0253791192370347	0.0957804713210053	1	1	0.999609384753994	0.999609384753994	0.83800622624293
up	TLR3; HSPA1B; WNT5A; RIPK4; CX3CL1; ROR1; RAB7B;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	7	154	4.54545454545455	0.0256260212069079	0.0966092812273207	1	1	0.999609384753994	0.999609384753994	0.845257682122035
up	ERBB2; NOS1; PAX9; SFRP1;	GO:0071363~cellular response to growth factor stimulus	4	59	6.77966101694915	0.0258780983622832	0.0972622100733378	1	1	0.999609384753994	0.999609384753994	0.850970312585318
up	APOE; CYP2E1; PCSK9;	GO:0006641~triglyceride metabolic process	3	33	9.09090909090909	0.0258816389517187	0.0972622100733378	1	1	0.999609384753994	0.999609384753994	0.850970312585318
up	RHOD; CDH13; AJUBA;	GO:0030032~lamellipodium assembly	3	33	9.09090909090909	0.0258816389517187	0.0972622100733378	1	1	0.999609384753994	0.999609384753994	0.850970312585318
down	CCR2; FABP5; IL18; IRF4;	GO:0120162~positive regulation of cold-induced thermogenesis	4	97	4.12371134020619	0.0259981354044572	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
up	HAS3; B4GALT2; FUT1; ME1; B4GALNT1; HYAL2;	GO:0005975~carbohydrate metabolic process	6	121	4.95867768595041	0.0263570048507554	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
down	TAL1; WNT1; GATA1;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0264320263030067	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
down	HLA-DQA2; HLA-DQB2; HLA-DMB; FCGR2B;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	4	98	4.08163265306122	0.0268306134761871	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
down	EREG; IL2RA; FLT3; CCR5; IL5RA; IL18; EPGN;	GO:0000165~MAPK cascade	7	254	2.75590551181102	0.0268803890900885	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
up	GXYLT2; GALNT5; MUC20; MUC4;	GO:0016266~O-glycan processing	4	60	6.66666666666667	0.0272269856998285	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	ERBB2; KITLG; AJUBA; ROBO1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.0272269856998285	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	B4GALT2; FUT1; FUT6; B3GALNT1; B3GALT5;	GO:0006486~protein glycosylation	5	90	5.55555555555556	0.0275003138064596	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
down	A2ML1; CSTA; SERPINB13; SERPINB2; SERPINB12;	GO:0010951~negative regulation of endopeptidase activity	5	148	3.37837837837838	0.0279970363437848	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
up	DLL1; LRP5; NPR1; EDNRA;	GO:0008217~regulation of blood pressure	4	61	6.55737704918033	0.0286171210520538	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	ANXA1; VCAM1; HES1; CD276;	GO:0042102~positive regulation of T cell proliferation	4	61	6.55737704918033	0.0286171210520538	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	MEIS2; SOX2; ZDHHC16;	GO:0001654~eye development	3	35	8.57142857142857	0.0297967249284956	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	PDPN; SLC6A15; SLC7A8;	GO:0003333~amino acid transmembrane transport	3	35	8.57142857142857	0.0297967249284956	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	KLK8; MDK; SOX2; TMPRSS4;	GO:0009611~response to wounding	4	62	6.45161290322581	0.0300486821860888	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	APOE; ISL1; TYRO3; CXCL17; FNDC4;	GO:0050728~negative regulation of inflammatory response	5	93	5.37634408602151	0.0308876032459262	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
down	S100B; PTPRZ1; LILRB2;	GO:0007611~learning or memory	3	59	5.08474576271187	0.0313755466585945	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
up	NQO1; IGFBP2; ALDH3A1; LIPG;	GO:0007584~response to nutrient	4	63	6.34920634920635	0.0315218231354488	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	HSPA1B; ANO1; TRPV4; SLC52A3;	GO:0034605~cellular response to heat	4	63	6.34920634920635	0.0315218231354488	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	HSPA1B; GPX3; GJB2; PYCR1; GPX8;	GO:0034599~cellular response to oxidative stress	5	94	5.31914893617021	0.0320721843022539	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
down	ATP10A; ATP2C2; ATP12A; ATP13A4; ATP6V1C2; RYR2;	GO:0034220~ion transmembrane transport	6	208	2.88461538461538	0.0324204737246756	0.108240647928222	1	1	0.97926915095487	0.97926915095487	0.867709116295312
up	WWTR1; FBXL7; FBXL2; FBXO27; FBXO17;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	5	95	5.26315789473684	0.0332847642070395	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	PTN; EGFLAM; EGFL6;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.0340055801785291	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	CLDN7; CRYAB; ISL1;	GO:0031333~negative regulation of protein-containing complex assembly	3	37	8.10810810810811	0.0340055801785291	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	HSPA1B; HSPA2; PPIC;	GO:0042026~protein refolding	3	37	8.10810810810811	0.0340055801785291	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	SLC26A4; SLC9A3; WNK4; SLC24A3; STEAP1;	GO:0006811~ion transport	5	96	5.20833333333333	0.0345254819721562	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	VCAM1; EMP2; FERMT2; MUC4; ITGB6;	GO:0007160~cell-matrix adhesion	5	96	5.20833333333333	0.0345254819721562	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	HPGD; LTBP2; PARD3; FERMT2; CGN;	GO:0007179~transforming growth factor beta receptor signaling pathway	5	96	5.20833333333333	0.0345254819721562	0.0987595630321583	1	1	0.999609384753994	0.999609384753994	0.864071011350617
up	MDK; DOCK1; HAS2;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	3	38	7.89473684210526	0.0362192716149667	0.100404245510558	1	1	0.999609384753994	0.999609384753994	0.878460731280813
down	IL2RA; FCER2; NRARP; CHAC1;	GO:0007219~Notch signaling pathway	4	109	3.6697247706422	0.0370384739372707	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
down	EREG; GJB6; OSM; GATA1; SSTR3; FGFBP1; BNIPL; TESC; SIRPG;	GO:0008285~negative regulation of cell population proliferation	9	396	2.27272727272727	0.0376231224086052	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
up	PSCA; FBLN1; CNKSR3; SPRY4;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	4	67	5.97014925373134	0.0378324518626637	0.104712181074143	1	1	0.999609384753994	0.999609384753994	0.916151888723953
up	TK1; CKB; CKMT1A; ITPKC; ETNK2;	GO:0016310~phosphorylation	5	99	5.05050505050505	0.0384177032726243	0.106166018411468	1	1	0.999609384753994	0.999609384753994	0.928871858920579
up	TAX1BP3; EPHA2; WNT5A; ARHGEF16; SYDE1;	GO:0090630~activation of GTPase activity	5	99	5.05050505050505	0.0384177032726243	0.106166018411468	1	1	0.999609384753994	0.999609384753994	0.928871858920579
up	BMP7; PRRX1; HOXC10;	GO:0030326~embryonic limb morphogenesis	3	39	7.69230769230769	0.0385052038933822	0.106241949947446	1	1	0.999609384753994	0.999609384753994	0.929536202069452
up	GNA15; GPR157; LPAR3;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	3	39	7.69230769230769	0.0385052038933822	0.106241949947446	1	1	0.999609384753994	0.999609384753994	0.929536202069452
down	PF4; TAL1; FUT3; SLA; LTK;	GO:0042127~regulation of cell population proliferation	5	163	3.06748466257669	0.0394185560863582	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
up	KCNJ5; FXYD3; KCNS3; KCNF1;	GO:0006813~potassium ion transport	4	68	5.88235294117647	0.0395149930015908	0.108540028651954	1	1	0.999609384753994	0.999609384753994	0.94964264168301
down	SSTR3; CNR2; HRH2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	3	65	4.61538461538462	0.039630536257205	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
down	TYROBP; FASLG; UACA;	GO:0097190~apoptotic signaling pathway	3	65	4.61538461538462	0.039630536257205	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
down	ICAM3; CLEC10A; CLEC4C; CLEC4A;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	4	112	3.57142857142857	0.04015948691795	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
up	DHCR24; MSMO1; CYP51A1;	GO:0006695~cholesterol biosynthetic process	3	40	7.5	0.0408628551101156	0.110761490880405	1	1	0.999609384753994	0.999609384753994	0.969078745443313
down	ELANE; CTSG; MMP8;	GO:0022617~extracellular matrix disassembly	3	66	4.54545454545455	0.0411029890962066	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
down	CEACAM6; DSG1; CD84; IGSF9B; NECTIN4;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	5	165	3.03030303030303	0.0411263752880637	0.117702046119346	1	1	0.97926915095487	0.97926915095487	0.943556236766928
up	CCND1; HMGA2; ADGRF5; WNT5B;	GO:0045444~fat cell differentiation	4	70	5.71428571428571	0.0430061411627571	0.116481820746871	1	1	0.999609384753994	0.999609384753994	1
up	PDPN; SLC6A15; SLC7A8;	GO:0006865~amino acid transport	3	41	7.31707317073171	0.0432916504854595	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	PLK1; KLHL13; PLK2;	GO:0032465~regulation of cytokinesis	3	41	7.31707317073171	0.0432916504854595	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	ADCY6; ADORA2B; UCN2; LGR4; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	5	103	4.85436893203883	0.0440079559335391	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
down	UPK3A; VIL1; SPINK5;	GO:0030855~epithelial cell differentiation	3	68	4.41176470588235	0.0441295291032104	0.119149728578668	1	1	0.97926915095487	0.97926915095487	0.955161555946908
down	OSM; GATA1; TAL1;	GO:1902036~regulation of hematopoietic stem cell differentiation	3	68	4.41176470588235	0.0441295291032104	0.119149728578668	1	1	0.97926915095487	0.97926915095487	0.955161555946908
up	FBLN1; BDKRB1; XDH; WWTR1;	GO:0001933~negative regulation of protein phosphorylation	4	71	5.63380281690141	0.0448147209315002	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	CDH1; NQO1; SLC6A1; SLC7A8;	GO:0009636~response to toxic substance	4	71	5.63380281690141	0.0448147209315002	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	CDH11; GRIK2; PLCB4; NTF4;	GO:0050804~modulation of chemical synaptic transmission	4	71	5.63380281690141	0.0448147209315002	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	SOX15; SOX2; HMGA2; ZNF462; PADI3; FOXA2;	GO:0006325~chromatin organization	6	139	4.31654676258993	0.0456326520535486	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	SLC26A4; CA12; SLC4A11;	GO:0015701~bicarbonate transport	3	42	7.14285714285714	0.0457909652642954	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	RAB34; RAB3B; RAB7B; RAB13;	GO:0032482~Rab protein signal transduction	4	72	5.55555555555556	0.046665251687712	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	CRYAB; NGFR; SFN; DHCR24;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	72	5.55555555555556	0.046665251687712	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	BVES; HSPA1B; HSPA2; SYT8; SYT12; ARL4D;	GO:0016192~vesicle-mediated transport	6	141	4.25531914893617	0.048199492007898	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	RGS12; RGS20; GNG4;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	3	43	6.97674418604651	0.0483601275143652	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	MMP2; MMP10; MMP19;	GO:0030574~collagen catabolic process	3	43	6.97674418604651	0.0483601275143652	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
up	NTN1; DHCR24; CNKSR1; PLK2;	GO:0007265~Ras protein signal transduction	4	73	5.47945205479452	0.0485576684436868	0.116999068056891	1	1	0.999609384753994	0.999609384753994	1
